JournalofConsultingandClinicalPsychology ©2012AmericanPsychologicalAssociation
2012,Vol.80,No.5,750–765 0022-006X/12/$12.00 DOI:10.1037/a0028310
Randomized Clinical Trial of Cognitive Behavioral Therapy (CBT) Versus
Acceptance and Commitment Therapy (ACT) for Mixed Anxiety Disorders
Joanna J. Arch Georg H. Eifert
UniversityofColoradoBoulder ChapmanUniversity
Carolyn Davies Jennifer C. Plumb Vilardaga
UniversityofCalifornia,LosAngeles UniversityofNevada,Reno
Raphael D. Rose and Michelle G. Craske
UniversityofCalifornia,LosAngeles
Objective: Randomized comparisons of acceptance-based treatments with traditional cognitive behavioral
therapy(CBT)foranxietydisordersarelacking.Toaddressthisgap,wecomparedacceptanceandcommit-
ment therapy (ACT) to CBT for heterogeneous anxiety disorders. Method: One hundred twenty-eight
individuals(52%female,meanage(cid:1)38,33%minority)with1ormoreDSM–IVanxietydisordersbegan
treatmentfollowingrandomizationtoCBTorACT;bothtreatmentsincludedbehavioralexposure.Assess-
mentsatpre-treatment,post-treatment,and6-and12-monthfollow-upmeasuredanxiety-specific(principal
disorderClinicalSeverityRatings[CSRs],AnxietySensitivityIndex,PennStateWorryQuestionnaire,Fear
Questionnaireavoidance)andnon-anxiety-specific(QualityofLifeIndex[QOLI],AcceptanceandAction
Questionnaire–16[AAQ])outcomes.Treatmentadherence,therapistcompetencyratings,treatmentcredibil-
ity, and co-occurring mood and anxiety disorders were investigated. Results: CBT and ACT improved
similarlyacrossalloutcomesfrompre-topost-treatment.Duringfollow-up,ACTshowedsteeperlinearCSR
improvementsthanCBT(p(cid:2).05,d(cid:1)1.26),andat12-monthfollow-up,ACTshowedlowerCSRsthanCBT
amongcompleters(p(cid:2).05,d(cid:1)1.10).At12-monthfollow-up,ACTreportedhigherAAQthanCBT(p(cid:1)
.08,d(cid:1)0.42;completers:p(cid:2).05,d(cid:1)0.56),whereasCBTreportedhigherQOLIthanACT(p(cid:2).05,d(cid:1)
0.42).Attritionandcomorbidityimprovementsweresimilar;ACTusedmorenon-studypsychotherapyat
6-monthfollow-up.Therapistadherenceandcompetencyweregood;treatmentcredibilitywashigherinCBT.
Conclusions:OverallimprovementwassimilarbetweenACTandCBT,indicatingthatACTisahighly
viabletreatmentforanxietydisorders.
Keywords:cognitivebehavioraltherapy,acceptanceandcommitmenttherapy,anxietydisorders
Supplementalmaterials:http://dx.doi.org/10.1037/a0028310.supp
Severaldecadesago,thedevelopmentofbehavioralandcogni- phobia,andposttraumaticstressdisorder,relativetowaitlistand/or
tive behavioral therapy for anxiety disorders (Barlow & Cerny, psychological control conditions. As a result of clinical efficacy
1988;Beck,Emery,&Greenberg,1985)introducedtime-limited, and ease of implementation, cognitive behavioral therapy (CBT)
relativelyeffectivetreatments.Numerousrandomizedclinicaltri- hasbecomethedominantempiricallyvalidatedtreatmentforanx-
als and meta-analyses (e.g., Butler, Chapman, Forman, & Beck, iety disorders. However, a significant percentage of individuals
2006; Hofmann & Smits, 2008; Norton & Price, 2007; Tolin, with anxiety disorders do not respond to CBT (e.g., Barlow,
2010) have demonstrated the effectiveness of CBT for anxiety Gorman, Shear, & Woods, 2000), relapse following successful
disorders, including panic disorder, generalized anxiety disorder, treatment (Brown & Barlow, 1995), seek additional treatment
social anxiety disorder, obsessive-compulsive disorder, specific (Brown & Barlow, 1995), or remain vulnerable to developing
ThisarticlewaspublishedOnlineFirstMay7,2012. to Chick Judd and Kate Wolitzky-Taylor for sound statistical advice.
JoannaJ.Arch,DepartmentofPsychologyandNeuroscience,Universityof Thank you to the many research assistants (over one dozen) who
Colorado Boulder; Georg H. Eifert, Department of Psychology, Chapman assisted in data collection, the many graduate student therapists, and
University;CarolynDavies,DepartmentofPsychology,UniversityofCali- aboveall,theindividualswhoparticipatedinthestudy.Specialthanks
fornia,LosAngeles;JenniferC.PlumbVilardaga,DepartmentofPsychology, to Kathleen McGrath and colleagues for conducting the treatment
University of Nevada, Reno; Raphael D. Rose and Michelle G. Craske, reliabilityratings.
DepartmentofPsychology,UniversityofCalifornia,LosAngeles. CorrespondenceconcerningthisarticleshouldbeaddressedtoMichelle
Thank you to Daniel Dickson and Milena Stoyanova for study G.Craske,DepartmentofPsychology,405HilgardAvenue,LosAngeles,
coordination,toJohnForsythforhelpwithinitialstudyplanning,and CA90095-1563.E-mail:craske@psych.ucla.edu
750
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 751
anxietyandmooddisordersthroughoutthelifespan(seeCraske, changethecontextbychallengingtheneedtorespondrigidlyand
2003). Further, the cognitive model, which posits that anxiety literally to cognitions in ACT) and uncomfortable internal expe-
disordersstemfromfaultycognitionsandaretreatedbymodifying riences(tomasterandreduceanxietyinCBTvs.opentowardand
thecontentofthesecognitions,hasbeenchallengedbyinsufficient acceptanxietyinACT)andthatpromotedifferenttreatmentgoals
supporting evidence (see Longmore & Worrell, 2007) and theo- (anxietyreductioninCBTvs.livingavaluedlifeinACT).
reticalarguments(seeBrewin,1996). ThecurrentstudycomparesACTandCBTinamixedanxiety
In attempt to broaden, improve upon, and provide theoretically disorderssamplefortworeasons.First,ACT(Hayesetal.,1999)
strongalternativestotraditional(cognitivemodel-based)CBT,clini- originallywasdevelopedforthetreatmentofpsychopathologyin
cal researchers have shown increasing interest in mindfulness and general rather than a specific disorder in particular. The ACT
acceptance-basedtreatmentsforpsychopathology.Multipletreatment protocol used in the current study (Eifert & Forsyth, 2005) was
approacheshavedevelopedoutofthisexploration,includingaccep- designed for application across all of the anxiety disorders, with
tance and commitment therapy (ACT; Hayes, Strosahl, & Wilson, the content of values-guided behavioral exercises tailored to spe-
1999), a behavioral therapy that cultivates mindfulness, acceptance, cific anxiety disorders. Second, CBT shares common treatment
cognitive defusion (flexible distancing from the literal meaning of elements across the anxiety disorders with variation in content
cognitions),andotherstrategiestoincreasepsychologicalflexibility specific to each disorder. We thus designed a CBT manual that
andpromotebehaviorchangeconsistentwithpersonalvalues.Within addressedallanxietydisordersviabranchingmechanismsspecific
ACT,psychologicalflexibilityisdefinedasenhancingthecapacityto to each disorder. Our CBT protocol included the same basic
makecontactwithexperienceinthepresentmoment,andbasedon treatmentelementsacrossallofthedisorders(e.g.,psychoeduca-
whatispossibleinthatmoment,persistinginorchangingbehaviorin tion, cognitive restructuring, exposure—see Method section) but
the pursuit of goals and values (Hayes et al., 1999). Case studies, tailoredthecontentoftheseelementstoeachspecificdisorder,an
multiple-baselinetreatmentstudies,andasinglerandomizedclinical approach we have successfully tested in previous studies (e.g.,
trialprovidenascentevidencethatACTisaneffectivetreatmentfor Craskeetal.,2011).
anxietydisorders,includingobsessive-compulsivedisorder(Twohig We assessed patients at four longitudinal measurement points,
et al., 2010), social anxiety disorder (Dalrymple & Herbert, 2007), including pre-treatment, post-treatment, 6-month follow-up, and
panic disorder (Eifert et al., 2009), generalized anxiety disorder 12-month follow-up, providing a thorough assessment of
(Wetherelletal.,2011),andposttraumaticstressdisorder(Orsillo& treatment-relatedchangeovertime.Duetolimitedextantdata,we
Batten, 2005). However, no randomized clinical trials for anxiety didnotmakespecificpredictionsregardingwhetheronetreatment
disordershaveyetcomparedACTwiththegold-standardtherapyfor wouldleadtogreaterreductionsinanxietydisorder-relatedsymp-
anxietydisorders,CBT. toms than the other treatment. Rather, investigating this question
SeveralstudieshavecomparedACTandCBTwithingeneralclinic represented a central study aim. However, given the emphasis in
samples. One randomized effectiveness trial (n (cid:1) 101) in undiag- ACT on psychological flexibility and valued living, we hypothe-
nosedanxiousanddepressedpatients(Forman,Herbert,Moitra,Yeo- sized that these measures would improve to a greater degree
mans,&Geller,2007)comparedACTandCBT,1concludingthatthe followingACTthanCBT.
twotreatmentswereequallyeffectiveacrosssymptomoutcomemea-
suresbutoperatedviasomewhatdifferentmechanisms.Asmall(n(cid:1)
Method
28)randomizedtreatmentstudycomparingACTandCBTforundi-
agnosed“generalclinicpatients”(Lappalainenetal.,2007)foundthat
Participants
ACTreducedsymptomstoagreaterdegreethanCBTandaffected
treatmentprocessesatadifferentrate.Inneitherstudy,however,were One hundred and forty-three participants meeting Diagnostic
anxietydisordersformallydiagnosed,significantlylimitingthecon- and Statistical Manual of Mental Disorders (4th ed.; DSM–IV;
clusions for the treatment of anxiety disorders. Roemer and Orsillo AmericanPsychiatricAssociation,1994)criteriaforadiagnosisof
(2007; Roemer, Orsillo, & Salters-Pedneault, 2008) developed an one or more anxiety disorders, including panic disorder with or
acceptance-based treatment for generalized anxiety disorder (GAD) without agoraphobia (PD/A), social anxiety disorder (SAD), spe-
thatintegratedseveralACTprinciplesandfoundittobesignificantly cific phobia (SP), obsessive-compulsive disorder (OCD), or gen-
superior to a waitlist control group for the treatment of generalized eralizedanxietydisorder(GAD),2wererandomizedtoACT(n(cid:1)
anxietydisorder.However,thispromisingtreatmentwasdeveloped 65)orCBT(n(cid:1)78).Allparticipantswhobegantreatment(n(cid:1)
forgeneralizedanxietydisorderalone,andithasnotyetbeencom- 128) were included in the intent-to-treat (ITT) sample (n (cid:1) 57
paredtoanotheractivetreatment. ACT, n (cid:1) 71 CBT). See Table 1 for ITT sample characteristics
Insummary,importantworkhasbeguntoinvestigateACTfor
anxiety disorders, but studies to date have not compared ACT to
themostevidence-basedpsychotherapyforthemajorityofanxiety 1The study called their approach “cognitive therapy,” which they de-
fined as the Beck-based treatment subtype of CBT (see Forman et al.,
disorders,CBT.DirectlycomparingtraditionalCBTandACTfor
2007).
anxietydisorderswithinarandomizedclinicaltrialbridgesavital
2Onlyfourparticipantsmetprincipaldiagnosisofposttraumaticstress
gap in the empirical treatment literature, fulfilling the gold-
disorder(PTSD),perhapsbecauseourrecruitmentmaterialsstated“anxiety
standard method for investigating the relative efficacy of two
disorders”butnot“trauma,”thereforeattractingfewerPTSDparticipants.
treatments for anxiety disorders (Chambless & Hollon, 1998).
Of these, one did not begin treatment, one dropped treatment, and two
Further, it provides an opportunity to compare the efficacy of completedtreatment.Duetotheverysmallsamplesizeforthisdisorder
treatmentpackagesthatcontaindistinctstrategiesfordealingwith (threetotalPTSDparticipantswhobegantreatmentandonlyoneinACT),
maladaptivecognitions(changethecontentofthoughtsinCBTvs. theseparticipantswereexcludedfromanalyses.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
752 ARCHETAL.
Table1
DemographicandClinicalCharacteristicsoftheIntent-to-TreatSample
Characteristic Total(n(cid:1)128) ACT(n(cid:1)57) CBT(n(cid:1)71) tor(cid:5)2 p
Gender
Female 52.3%(67/128) 50.0%(28/56) 54.9%(39/71) 0.43 .51
Reportedrace/ethnicity 0.82 .36a
White 67.2%(84/125) 71.4%(40/56) 63.8%(44/69)
Hispanic/Latino/a 12.0%(15/125) 10.7%(6/56) 13.0%(9/69)
AfricanAmerican/Black 8.8%(11/125) 7.1%(4/56) 10.1%(7/69)
AsianAmerican/PacificIslander 8.0%(10/125) 8.9%(5/56) 7.2%(5/69)
AmericanIndian/AlaskanNative 0.08%(1/125) 1.8%(1/56) 0.0%(0/69)
Ageinyears,M(SD) 37.93(11.70)range:19–60 38.16(12.41) 37.75(11.19) (cid:6)0.20 .85
Educationinyears,M(SD) 15.41(2.07)range:9–21 15.59(2.01) 15.27(2.12) (cid:6)0.86 .39
Maritalstatus 0.19 .91a
Married/cohabiting 32.3%(41/127)b 32.1%(18/56) 32.4%(23/71)
Single 58.3%(74/127) 57.1%(32/56) 59.2%(42/71)
Other 10.2%(13/127) 10.7%(6/56) 8.5%(6/71)
Children(1(cid:7)) 28.0%(35/125) 30.4%(17/56) 26.1%(18/69) 0.28 .60
Currentlyonpsychotropicmedication 48.0%(61/127) 44.6%(25/56) 50.7%(36/71) 0.46 .50
Primarydiagnosis 4.67 .32
Panicdisorder(withorwithoutagoraphobia) 41.7%(53/127) 32.1%(18/56) 49.3%(35/71) 3.79 .052
Socialanxietydisorder 19.7%(25/127) 23.2%(13/56) 16.9%(12/71) 0.79 .37
Generalizedanxietydisorder 20.5%(26/127) 25.0%(14/56) 16.9%(12/71) 1.26 .26
Obsessive-compulsivedisorder 13.4%(17/127) 16.1%(9/56) 11.3%(8/71) 0.62 .43
Specificphobia 4.7%(6/127) 3.6%(2/56) 5.6%(4/71) .69d
Comorbidanxietydisorder(1(cid:7))c 33.1%(42/127) 39.3%(22/56) 28.2%(20/71) 1.75 .19
Comorbiddepressivedisorderc 23.6%(30/127) 23.2%(13/56) 23.9%(17/71) 0.01 .92
PrincipaldisorderclinicalseverityratingatPre,M(SD) 5.62(0.92) 5.70(0.89) 5.55(0.94) 0.94 .35
Note. ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy;Pre(cid:1)pre-treatment.
aFor race/ethnicity and marital status, analyses assessed group differences in minority versus White and married versus non-married sta-
tus. bDemographicdataweremissingforoneparticipant. cComorbiditywasdefinedasaclinicalseverityratingof4oraboveontheAnxietyDisorders
InterviewSchedule–IV(ADIS–IV). dFisher’sexacttestpvaluewasreportedduetosmallsamplesize.
and Figure 1 for patient flow. Fifteen of the original 143 partici- Also, participants were psychotherapy free or stabilized on alter-
pants, blinded to treatment randomization (unaware if they had nativepsychotherapiesotherthancognitiveorbehavioraltherapies
been randomized to ACT or CBT), dropped prior to treatment that were not focused on their anxiety disorder, for at least 6
initiation. Because pre-treatment attrition gave us no information months prior to study entry. Participants were encouraged not to
abouttreatmentpreferenceorresponse,wedidnotanalyzethose change their non-study medication or alternative psychotherapy
participants further. Participants who dropped prior to treatment during the course of the study. Exclusion criteria included active
didnotdiffersignificantlyfromparticipantswhobegantreatment suicidal ideation; severe depression (CSR (cid:4) 6 on ADIS–IV; see
on any sociodemographic variable from Table 1 (ps (cid:1) .20), nor below); or a history of bipolar disorder, psychosis, mental retar-
did not differ by blind assignment to ACT versus CBT (n (cid:1) 8 dation,ororganicbraindamage.Participantswithsubstanceabuse
each,p(cid:1).66).Participantswhodroppedtreatmentshowedsome- or dependence within the last 6 months or with respiratory, car-
what higher Clinical Severity Ratings (CSRs; M (cid:1) 6.07, SD (cid:1) diovascular, pulmonary, neurological, muscular-skeletal diseases,
0.96) relative to participants who began treatment (M (cid:1) 5.63, orpregnancywereexcluded.
SD (cid:1) 0.92), but group differences were small and did not reach Participants received 12 weeks of reduced-cost, sliding scale
statistical significance (p (cid:1) .08, (cid:3)2 (cid:1) .02). Eleven of the 15 ($0–100/session) individual treatment and received $15–$25 in
p
participants (73%) dropped prior to completing the pre-treatment cashoragiftcertificateuponcompletionofthepost-treatmentand
questionnaire assessment; therefore, we could not determine if each follow-up assessment. Participants were reimbursed for
they differed from participants who initiated treatment on ques- UCLAparkingfeesfortheassessments($8–$10).Thestudywas
tionnairemeasures. fully approved by the UCLA human subjects protection commit-
Participants were recruited from the Los Angeles area in re- tee; full informed consent was obtained from all participants,
sponse to local flyers, Craigslist and local newspaper advertise- includingforvideo-andaudiorecordings.
ments,andreferrals.ThestudytookplaceattheAnxietyDisorders
Research Center at the University of California Los Angeles
Design
(UCLA),DepartmentofPsychology.
Participants were either medication free or stabilized on psy- Participantswereassessedatpre-treatment(Pre),post-treatment
chotropic medications for a minimum standard length of time (1 (Post),andat6months(6mFU)and12months(12mFU)afterPre.
monthforbenzodiazepinesandbetablockers,3monthsforselec- Assessmentsincludedadiagnosticinterview,self-reportquestion-
tive serotonin reuptake inhibitors [SSRIs] or serotonin– naires, and a 2- to 3-hr laboratory assessment (except at 6mFU)
norepinephrine reuptake inhibitors [SNRIs] and heterocyclics). reported elsewhere. Assessors were blind to treatment condition.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 753
Assessed for Eligibility
DC (cid:1)io dm np Dol te i dt pe a nd r o tp tic h qipo uan ate le if ys in c d r i ue n re t ia nn k gin e pg i h n( otn e nr= ev i2 se9 cw4 r e) ( en n= in6 g9 () n=14) E (cid:1)xclu Dd ie dd n o(n t m= e8 e7 t) inclusion criteria (n=65)
(cid:1) Invited to participate but chose not to (n=55) (cid:1) Lost contact with study(n=10)
Participated in intake interview (n=225) (cid:1) Declined participation (n=4)
o Reasons: schedule (n=2), uncomfortable
with being recorded (n=1), no reason
given (n=1)
(cid:1) Excluded from further analysis for diagnostic
reasons: principal PTSD (n= 4)
Enrollment
Lost to Pre-Assessment (n=15)
(cid:1) Lost contact with study (n=6), moved
Randomized (n=143) (n=1), began other treatment (n=1),
too anxious (n=1), no longer
interested (n=1), no reason given
(n=5)
Allocation
Allocated to CBT(n=71) Allocated to ACT(n=57)
Treatment
Fewer than ½ Rxsessions (n= 15) Fewer than ½ Rxsessions (n= 12) Completed all 12 sessions (n= 49) Completed all 12 sessions (n= 38)
Average sessions attended = 9.6 Average sessions attended = 9.4
Lost to Post (n=23) Follow-Up Lost to Post (n=20)
(cid:1)Drop by PI (n=4) 2 due to new ineligible (cid:1) Drop by PI (n=1) referred out due to need
medical conditions, 1 due to new meds, 1 for more intensive treatment for suicidal
due to new psychotherapy during CBT depression
(cid:1)Transportation (n=1), schedule (n=1), not (cid:1) No longer interested (n=2), “too anxious” to
satisfied with treatment (n= 3), lost complete treatment (n=2), other (n=3), lost
contact/unknown (n=14) contact/unknown (n=12)
Lost to Follow-Up 1 (n=12) Lost to Follow-Up 1 (n=10)
(cid:1)Moved (n=1), schedule (n=1), declined (cid:1) Moved (n=1), schedule (n=1), declined
(n=1), lost contact/ unknown (n=9) (n=1), lost contact /unknown (n=7)
Lost to Follow-Up 2 (n=5) Lost to Follow-Up 2 (n=4)
(cid:1)Lost contact/ no reason given (n=5) (cid:1) Schedule (n=2), lost contact/ no reason
given (n=2)
Analysis
Analyzed (n=71) Analyzed (n=57)
Figure1. Patientflowforthestudy.PTSD(cid:1)posttraumaticstressdisorder;ACT(cid:1)acceptanceandcommit-
menttherapy;CBT(cid:1)cognitivebehavioraltherapy;Rx(cid:1)treatment;PI(cid:1)principalinvestigator.
Randomizationsequenceswereproducedbyhttp://www.randomizer basedondetailedtreatmentmanualsdeliveredbydoctoralstudent
.org; therapists were requested not to inform participants of their therapists.3 If clients presented with multiple anxiety disorders,
assignedtreatmentcondition.Forthefirsttwoquartersofthestudy, treatment focused on the principal disorder. Following the 12
participantswererandomized1:1CBTtoACT.Inthethirdquarter, sessions, therapists conducted follow-up phone calls once per
participants were randomized 2:1 CBT to ACT due to the greater monthfor6months,allowing20–35minpercalltocheckinand
availabilityofCBT-trainedtherapists.Inthefinalquarter,toequalize troubleshoot in a manner consistent with the assigned therapy
condition assignments, participants were randomized 1:2 CBT to condition, to enhance long-term outcomes (see Craske et al.,
ACT. Because fewer participants were recruited in the fourth com- 2006).
paredtothethirdquarter,thetotalnumberofparticipantswhobegan
treatmentineachconditionwasunequal(n(cid:1)57toACT;n(cid:1)71to
Therapists
CBT).Tomaximizestatisticalpowerforthemaingroupcomparison
hypotheses,wedidnotstratifypatientsonanyvariables. ClinicalpsychologydoctoralstudentsatUCLAservedasstudy
therapists.Themajorityoftherapistswererelativelyna¨ıvetoCBT
Treatments and ACT and inexperienced more generally (i.e., in their first or
FollowingthePreADIS–IVandlaboratoryassessments,partic-
ipants were randomized to treatment condition. Participants re- 3SeeauthorCraskeforacopyoftheCBTtreatmentmanual;theACT
ceived 12 weekly, 1-hr individual CBT or ACT therapy sessions manualhasbeenpublished(Eifert&Forsyth,2005).
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
754 ARCHETAL.
second year of treating patients).4 Therapists were assigned to anddiscussionthatintroducedacceptance,creativehopelessness,and
ACT, CBT, or both (i.e., treated in both CBT and ACT, though valuedaction.Creativehopelessnessinvolvedaprocessofexploring
neveratthesametime),dependingontheneedfortherapistsina whether efforts to manage and control anxiety had “worked” and
particular condition and the availability of training in that condi- experiencinghowsucheffortshadledtothereductionorelimination
tion (e.g., a multi-day training workshop with an ACT or CBT of valued life activities. Participants were encouraged to behave in
expert; see below). There were a total of 39 therapists; 18 thera- waysthatenactedtheirpersonalvalues(“valuedaction”),ratherthan
pists worked exclusively in CBT, 9 worked exclusively in ACT, spendtimemanaginganxiety.Acceptancewasexploredasanalter-
and 11 treated both ACT and CBT participants (but never at the nativetocontrollinganxiety.Sessions2–3furtherexploredcreative
same time). Generally, therapists treated one to two patients at a hopelessnessandacceptance.Sessions4and5emphasizedmindful-
time and three to six therapists worked within each treatment ness,acceptance,andcognitivedefusion,ortheprocessofexperienc-
condition at a time. The mean number of patients treated by inganxiety-relatedlanguage(e.g.,thoughts,self-talk,etc.)aspartof
CBT-onlytherapistswas1.94(SD(cid:1)1.16;range1–4)foratotal thebroader,ongoingstreamofpresentexperienceratherthangetting
of35participants,byACT-onlytherapistswas1.89(SD(cid:1)1.05; stuckinrespondingtoitsliteralmeaning.Sessions6–11continuedto
range 1–4) for a total of 17 participants, and by therapists who honeacceptance,mindfulness,anddefusionandaddedvaluesexplo-
treatedinbothconditionswas6.82(SD(cid:1)1.60;range4–9)fora ration and clarification with the goal of increasing willingness to
total of 75 participants. The mean patient number for therapists pursuevaluedlifeactivities.Behavioralexposures,includingintero-
treatinginbothconditionswassignificantlyhigherthanthemean ceptive,in-vivo,andimaginal,wereemployedasneededtoprovide
for ACT- or CBT-only therapists (ps (cid:2) .001, (cid:3)2 (cid:1) .77 for each opportunitiestopracticemakingroomfor,mindfullyobserving,and p
comparison; there were no differences between ACT- and CBT- acceptinganxiety(alltypesofexposure)andtopracticeengagingin
only therapists). This is because therapists were allowed to gain valuedactivitieswhileexperiencinganxiety(in-vivoexposures).Ses-
training in the second treatment modality (e.g., in CBT if they sion12reviewedwhatworkedandhowtocontinuemovingforward.
startedoutinACT)onlyiftheyhadseenatleastseveralpatients Seethesupplementalmaterialsforadditionaldetails.
intheiroriginalmodality(e.g.,inACT).Consequently,therapists
who treated in both conditions treated more patients overall. We Outcome Measures
testedthepossibility,therefore,thattherapiststreatingindifferent
conditions would evidence systematic differences in competency Because CBT emphasized symptom reduction, whereas ACT
thatimpactedstudyfindings(seeResultssection). emphasized broader aims of psychological flexibility and valued
Weekly, hour-long group supervision for study therapists was living,weinvestigatedtwosetsofprimaryoutcomesacrossboth
led separately by the principal authors of the treatment manuals treatments: anxiety-specific (i.e., symptom reduction related) and
and by advanced therapists from UCLA and from Dr. Hayes’ non-anxiety-specific, or broader, outcomes. For the anxiety-
laboratory at the University of Nevada Reno, where ACT was specific measures, we included the severity of each principal
originallydeveloped.Allsessionswerevideotapedforsupervision anxietydisorder.Inaddition,themixedanxietydisordernatureof
purposes with a hidden video camera; sessions were also audio- our sample required utilization of anxiety-specific outcome mea-
taped for therapy adherence purposes with a discrete digital re- suresthatwererelevantacrosstheanxietydisorders.Weselected
corder. Videos were generally played in supervision sessions or measures of worry, fear, and behavioral avoidance, features that
watchedbeforehandbysupervisors.ACTsupervisionoccurredby characterizeallanxietydisorders(Craskeetal.,2009),andempir-
phoneandSkypewithoffsitesupervisors,supplementedbyocca- icallytestedthemtoensurethattheychangedfollowingtreatment
sional face-to-face sessions, whereas CBT supervision was face- acrosstheentiresample(notmerelywithinasingledisorder).For
to-face. All therapists completed extensive training including an thenon-anxiety-specific,broadermeasuresweassessedqualityof
intensive 3-day workshop with the principal treatment manual lifeandpsychologicalflexibility.
author(authorCraskeforCBT,andauthorEifertorDr.Hayesfor
ACT)priortotreatingparticipants.ACTandCBTmanualswere Anxiety-Specific Primary Outcomes
matched on the number of sessions devoted to exposure but
Diagnostic interview assessment. Clinical diagnoses were
differedincopingskillsandtheframingofexposureintent.
ascertained using the Anxiety Disorders Interview Schedule–IV
Cognitivebehavioraltherapy(CBT). CBTforanxietydis-
(ADIS–IV;Brown,DiNardo,&Barlow,1994).Doctoralstudents
orders followed a protocol authored by Craske (2005), which
inclinicalpsychologyorresearchassistantsservedasinterviewers
involved a single manual with branching mechanisms that listed
aftercompleting15–20hroftraininganddemonstratingadequate
cognitive restructuring and behavioral exposure content for each
diagnostic reliability on three consecutive interviews. “Clinical
anxiety disorder. Session 1 focused on assessment, self-
severity ratings” (CSRs) were made for each disorder by group
monitoring,andpsychoeducation.Sessions2–4emphasizedcog-
consensus on a 0 to 8 scale (0 (cid:1) none, 8 (cid:1) extremely severe).
nitive restructuring with hypothesis testing, self-monitoring, and
Ratings of 4 or higher indicated clinical significance based on
breathing retraining. Exposure (e.g., interoceptive, in-vivo, and
symptom severity, distress, and disablement and served as the
imaginal) was tailored to the principal diagnosis and focused on
cutoff for study eligibility (see Craske et al., 2007). ADIS–IV
empiricism and anxiety reduction over time; it was introduced in
interviewswereaudiorecorded,and15%(n(cid:1)22)wererandomly
Session 5 and emphasized strongly in Sessions 6–11. Session 12
focusedonrelapseprevention.
Acceptanceandcommitmenttherapy(ACT). ACTforanx- 4Priortostudytraining,therapistshadreceivedonlyoneortwolectures
iety disorders followed a manual authored by Eifert and Forsyth onCBTandonelectureincorporatingthird-wavebehavioraltherapiesat
(2005).Session1focusedonpsychoeducation,experientialexercises, thepointofinitialstudyinvolvement.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 755
selected for blind rating by a second interviewer.5 Inter-rater tionoftreatmenteffects.Weexaminedthenumberofco-occurring
reliabilityontheprincipaldiagnosiswas100%.Inter-rateragree- anxiety disorders, the presence of co-occurring mood disorders,
mentondimensionalCSRratingswas.65withasingle-measure, andthetotalnumberofco-occurringanxietyandmooddisorders
one-waymixedintraclasscorrelation6coefficient(ICC)acrossthe asindicesofthegeneralizationoftreatmenteffects.
anxietydisorders.Inter-rateragreementforeachspecificdisorder
(met DSM–IV criteria vs. subclinical vs. none) was as follows: Treatment Credibility
SAD(10subclinicalorclinicalcases)andOCD(3cases)ICC(cid:1)
1.00 (100% agreement); PD/A (11 cases) ICC (cid:1) .91; GAD (8 Priortothesecondtherapysession,afterthetreatmentrationale
cases)ICC(cid:1).85;andSP(7cases)ICC(cid:1).75. had been fully described, participants completed a six-item treat-
The Anxiety Sensitivity Index (ASI; Peterson & Reiss, 1993; ment credibility questionnaire adapted from Borkovec and Nau
Reiss, Peterson, Gursky, & McNally, 1986)7 assesses fear of (1972; see supplemental materials). Total sample alpha was .94,
anxiety-relatedsensations(e.g.,shortnessofbreath)basedonthe ACTalphawas.92,andCBTalphawas.95.
belief that such sensations are harmful. Although particularly
elevated in panic disorder (Taylor, Koch, & McNally, 1992), the Treatment Adherence and Therapist Competence
ASIshowselevationacrossmostanxietydisorders(Rapee,Brown,
Antony,&Barlow,1992)relativetonon-anxiouscontrols(Peter- Treatmentsessionswereaudiotaped,and143sessionsfrom91
son&Reiss,1993).Currentsamplealphaswere.85(Pre)and.93 participants (50 in CBT, 41 in ACT) were randomly selected for
(Post). The Penn State Worry Questionnaire (PSWQ; Meyer, treatment adherence and therapist competency ratings using the
Miller, Metzger, & Borkovec, 1990) assesses clinically relevant DrexelUniversityACT/CTTherapistAdherenceandCompetence
worry.AlthoughparticularlyelevatedinGAD,thePSWQshows Rating Scale (DUACRS; McGrath, Forman, & Herbert, 2012).
elevations across all anxiety disorders relative to non-anxious The treatment adherence items (n (cid:1) 49) included five scales:
controls(Brown,Antony,&Barlow,1992).Currentsamplealphas GeneralTherapyAdherence(12items),GeneralBehavioralTherapy
were .90 (Pre) and .93 (Post). The Fear Questionnaire’s (FQ; Adherence(11items),CognitiveTherapyAdherence(10items),ACT
Marks&Mathews,1979)MainTargetPhobiaScale,asingle-item Adherence(16items),andTherapistCompetence(5items;seesup-
avoidanceratingforeachparticipant’s“mainphobia,”wasusedas plemental materials). The first author of the DUACRS (McGrath),
thebehavioralavoidanceoutcome. who had no involvement with the current study and extensive
training in both ACT and CBT, completed adherence ratings. To
checktreatmentintegrity,theblindrater(McGrath)notedwhichof
Broader (Non-Anxiety-Specific) Primary Outcomes
49 therapist adherence items (e.g., specific therapist behaviors or
The Quality of Life Inventory (QOLI; Frisch, 1994a, 1994b) therapy content) occurred in each 5-min segment of therapy.
assesses values and life satisfaction across 16 broad life domains Treatment-specific subscale scores (indicating adherence to ACT
andhasgoodtest–retestreliabilityandinternalvalidity(Frischet or CBT) were calculated by dividing the number of segments
al., 2005). Current alphas were .86 (Pre) and .84 (Post). The duringwhichsubscale-specifictherapistbehaviorwaspresent(i.e.,
AcceptanceandActionQuestionnaire–16(AAQ;Bond&Bunce, atleastoneoftheitemscomposingasubscalewascodedforthat
2000;Hayesetal.,2004)assessespsychologicalflexibility(Bond 5-min segment) by the total number of segments in the session,
et al., 2011). The AAQ is a 16-item version of the seven- and yielding an estimate of the percentage of time spent by the ther-
nine-itemAAQthatishypothesizedtobemoresensitivetoclinical apistontreatment-specificbehavior.TheGeneralTherapyAdher-
change (Hayes et al., 2004). Both one- and two-factor solutions ence and General Behavioral Therapy Adherence scales were
have been fit to the 16-item AAQ (Bond & Bunce, 2000, 2003). computedinsimilarmanner.Attheendofeachrecording,thera-
Herein,aone-factorscalewasused,withhigherscoresindicating pistcompetencewasratedandthemeanofthescaleitemsrepre-
greaterpsychologicalflexibility.Currentalphaswere.78(Pre)and sentedthetherapistcompetencyratingforthatsession.
.86 (Post). See supplemental materials for additional psychomet-
ricsonprimaryoutcomes. Statistical Analyses
Raw data were inspected graphically; outliers (3 SD) were
Secondary Outcomes
replacedwiththenexthighervalue,followingtheWinsormethod
(Guttman,1973),priortodataanalysis.Infullhierarchicallinear
Use of additional treatment. As a behavioral indication of
modeling(HLM)models(seebelow),Level1and2residualswere
thedegreetowhicheachtreatmentmetclients’needs,weassessed
examined for model outliers and fit, and outliers (3 SD) were
participants’ reported use of additional (non-study-related) psy-
chotherapy and psychotropic medication at Post-12mFU with
questions on the ADIS–IV. At each assessment point, we com-
5Giventhemixedanxietydisordersampleandsubsequentlylowsample
pared groups on the portion of participants who initiated new,
size per disorder, ICCs for individual disorders should be interpreted
dropped (e.g., among participants using therapy or medication at
cautiously. Note, however, that agreement was based on all 22 rated
thepreviousassessmentpoint),orwereusinganyform(e.g.,either audiotapes,notjusttheaudiotapesofparticipantswithclinicallysignificant
new or continued from the previous assessment) of non-study symptoms.
psychotherapyorpsychotropicmedication. 6Thistestwasselectedbecausethesecondinterviewersincludedseveral
Generalizationoftreatmenteffects. BasedontheADIS–IV differenttrainedassessorswhoratedseveraltapeseach.
interview,co-occurringmoodandanxietydisorders(withCSRsof 7We used the original ASI because the revised ASI–3 (Taylor et al.,
4(cid:7))atPost-12mFUwereanalyzedasanindexofthegeneraliza- 2007)hadnotyetbeenpublishedatstudyinitiation.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
756 ARCHETAL.
treatedintheWinsormethodandontwooccasions,eliminateddue Raudenbush, Bryk, Cheong, & Congdon, 2004), which utilize
toparticularlystronganduncorrectableinfluence.Lessthan5%of participantswithincompletedata.
thedataweremodifiedoreliminatedduringoutliercorrection. Threeseparateindicesexaminedtreatmentresponseintermsofthe
Longitudinal data were analyzed with HLM and hierarchical percentage of responders at each assessment point (Post, 6mFU,
multiple linear modeling (HMLM) in HLM 6.0 (Raudenbush, 12mFU); chi-square analyses examined between-group differences.
Bryk, & Congdon, 2004). HLM/HMLM random effects models Diagnosticstatusimprovementwasdefinedinaccordancewithrecent
examined within- and between-group change across time (Pre, clinical trials (Newman et al., 2011; Roemer et al., 2008) as a
Post, 6mFU, 12mFU) and by condition (ACT and CBT). HLM/ principal diagnosis CSR of 3 or below. Reliable change was com-
HMLMincorporatesparticipantswithmissingdatabyestimating putedusingtheJacobsonandTruax(1991)method,usingthemore
thebestfittingmodelfromthedataavailableforeachparticipant conservativedenominatorrecommendedbyMaassen(2004).Tore-
(Hedeker & Gibbons, 2006). Therefore, for the intent-to-treat mainconsistentwithpreviousrandomizedclinicaltrials,wefocused
(ITT) analyses, all data points for participants who entered treat- theresponseindicesonanxiety-specificoutcomes.Duetotherangeof
mentwereenteredintothemodel.Forcompleterresults,whichare principaldisordersandconservativemethodofdefiningchange,we
reported when different from ITT results, analyses included par- examinedgroupdifferencesinreliablechangeonatleasttwooffour
ticipants who completed treatment and at least one subsequent anxiety-specificprimaryoutcomes(reliablechangestatus),aswellas
assessment(Post,6mFU,12mFU).Infittingmodelstothelongi- reliablechangeplusfallingwithin1SDofthenon-clinicalnormative
range(or3orlessonCSR)onatleasttwooffouranxiety-specific
tudinal data, different variance–covariance structures were as-
primary outcomes (high end-state functioning status) and reliable sessed starting with the simplest, the HLM compound symmetry
change on the principal disorder CSR plus CSR of 3 or below
model.HLMmodelfitwascomparedwithmultipleHMLMLevel
(diagnosticchangestatus).Seesupplementalmaterialsforemployed
1variance–covarianceoptions(homogenous,heterogeneous,first-
norms and computations details and Table 6 for reliable change
orderautoregressive,unstructured)usingrestrictedloglikelihood
criticalvalues. values(–2LL)inchi-squarecomparisons(seeRaudenbush,Bryk,
Toassessifdataweremissingatrandom,weconductedchi-square
Cheong, & Congdon, 2004). The model with the best fit was
comparisons on primary outcomes comparing participants who
selected;ifmodelswerenotsignificantlydifferent,themodelwith
dropped out versus finished treatment and treatment finishers with thefewestparameterswasselected.
completeversusincompletedataat6mFUand12mFU.Fordropouts
IntheHLM/HMLMmodels,assessmenttimepoints(Pre,Post,
versus finishers, no significant differences emerged at Pre on any
6mFU, 12mFU) were entered on Level 1 and nested within indi-
primary outcome variable. For treatment finishers with complete
vidualsonLevel2.Demographicandclinicalcovariatesandgroup
versusincompletedata,nosignificantdifferencesemergedatPreor
(dummycodedACTvs.CBTandcenteredat(cid:6).5,.5)wereentered
Post,withtheminorexceptionthatparticipantswithincompleteFU
on Level 2. Between-group differences focused on group differ-
datahadhigherASIscoresatPre(p(cid:1).04,(cid:3)2(cid:1).05)butnotatPost.
ences in change slopes over time and at Post and 12mFU time p
Thefindingssuggestthatthedataweremissingatrandom.
points.InallHLM/HMLManalyses,alldatapointswereincluded Poweranalyses,conductedinOptimalDesign(seeRaudenbush
inthemodels.ForthePostand12mFUanalyses,theinterceptwas
&Liu,2000),indicatedthattoreach80%power,across-sectional
shiftedtoPostor12mFUtofacilitategroupcomparisonsatthose
between-group difference (e.g., at 12mFU) with an effect size of
time points. Due to curvilinear change patterns over time, qua-
0.70required67totalparticipants,whereasabetween-groupeffect
draticandcubictimetermsweretestedonLevel1andkeptinfinal
size of 0.50 required 126 total participants. Therefore, our total
models if they were significant and significantly reduced model sample size (n (cid:1) 128) was sufficient to detect between-group
deviance (–2LL) according to chi-square-based model compari-
differencesofmoderatesizeateachassessmentpoint.
sons. Cubic terms were fixed in order to not overestimate the
model’srandomeffects.Foranalysesofnon-CSRoutcomes,pre-
Results
CSR was covaried on the intercept to account for pre-treatment
diagnostic severity. Effect sizes for within-group change at each Pre-Treatment Group Differences
assessmentpointwereexaminedinmodelsthatincludedlinearand
quadratic slopes only for the sake of clarity and brevity and to At pre-treatment, ACT and CBT evidenced no significant dif-
avoid overinflating within-group linear effect sizes, which can ferences on anxiety-specific or broader outcome measures, al-
occurwhenbothquadraticandcubictermsareinthemodel.We though ASI differences approached significance, t(111) (cid:1) 1.91,
computeddeffectsizesthataccountedforthenumberofrepeated p (cid:1) .058 (all other outcomes, ps (cid:4) .2). Further, ACT (8.82%,
measurement periods as needed (Feingold, 2009)8 and used Co- 3/34) and CBT (9.68%, 3/31)9 showed no differences in use of
hen’s (1988) guidelines for interpretation. For ease of effect size non-studypsychotherapyatPre,(cid:5)2(cid:1)0.01,p(cid:1).91,norinuseof
comparisonsbetweentheITTandcompletersamples,weusedthe
ITTstandarddeviationsinalleffectsizecomputations.
8Wedidnotreport95%confidenceintervalsforourFeingold(2009)
Differencesinrateofimprovementshouldtranslateintodiffer-
effectsizesbecausethereisnotyetamethodfordoingso(seeFeingold,
ent outcomes at post-treatment or follow-up. Therefore, the Post
2009;Odgaard&Fowler,2010).
and 12mFU time points represented our main time points of
9Tocomplywithinstitutionalreviewboardrequirements,theoriginal
interestforexaminingcrosssectionalgroupdifferences.
ADIS–IVshadalreadybeenshredfortheremaininghalfofthesampleby
For comorbidity analyses, we compared groups at Pre using
thepointatwhichweextractedthesedata.Thereisnoreasontobelieve,
chi-square and over time using generalized hierarchical linear however, that the remaining half differed from the first half in use of
modeling (GHLM) random effects repeated-measure models (see non-studypsychotherapy.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 757
psychotropicmedication(seeTable1).ACTandCBTshowedno and both-type (e.g., treated participants in both CBT and ACT)
significantdifferencesonsocio-demographicorclinicalcharacter- therapistsoncompetence.CBT-only(M(cid:1)2.96,SD(cid:1)0.64)and
isticsinTable1,withoneexception.Despiterandomizationpro- ACT-only therapists (M (cid:1) 3.02, SD (cid:1) 0.62) showed no differ-
cedures,therewasatrendforhigherratesofaprincipaldiagnosis encesincompetence(p(cid:1).81),nordidACT-onlyandboth-type
of PD/A in CBT (49.3%) than in ACT (32.1%), (cid:5)2 (cid:1) 3.79, p (cid:1) therapists (p (cid:1) .13). Both-type therapists, however, showed sig-
.052.InHLManalyses,principalPD/Adiagnosispredictedsupe- nificantly higher competence (M (cid:1) 3.36, SD (cid:1) 0.72) than CBT-
riorCSRoutcomescomparedtonon-PD/Aprincipaldiagnoses,at onlytherapists(M(cid:1)2.96,SD(cid:1)0.64),F(1,73)(cid:1)5.18,p(cid:1).03,
Post(B(cid:1)–1.14,SE(cid:1)0.45),t(126)(cid:1)–2.53,p(cid:1).01,d(cid:1)1.24, (cid:3)2 (cid:1) .07. To determine if therapists who treated in a single
p
and at 6mFU (B (cid:1) –1.01, SE (cid:1) 0.51), t(126) (cid:1) –2.11, p (cid:1) .04, condition impacted study findings, we reran the CSR analyses
d (cid:1) 1.10, but not at 12mFU (B (cid:1) –0.62, p (cid:1) .26). Despite the twice, once without CBT-only therapists and once without CBT-
significantimpactofPD/AonCSRoutcomes,wedidnotcovary and ACT-only therapists. Although reduced power from a lower
PD/AinfurtherHLM/HMLManalysestoavoidfurtherstratifica- samplesize(whichmeanttheanalysesfellbelowthe80%statis-
tion of participants into additional subgroups that lacked a priori tical power level) meant that group differences were not statisti-
significanceandtoavoidreducedstatisticalpowertoexamineour cally significant, the pattern of findings for group differences
principalcomparisonofCBTversusACT.PrincipalPD/Adidnot matchedthosereportedforthefullsamplebelow,suggestingthat
predict other primary outcomes for which we found significant therapist assignment did not impact study findings. See supple-
CBTversusACTdifferences. mentalmaterialsforanexampleoftheseresults.
Treatment Credibility Treatment Attrition
Treatment credibility scores (immediately prior to Session 2) Eighty-five of 128 participants (66%) completed the full 12 ses-
differedsignificantlybygroup,F(1,76)(cid:1)9.08,p(cid:1).004,(cid:3)2(cid:1) sionsoftherapy,including68%(48/71)inCBTand65%(37/57)in
p
.11, with CBT evidencing higher scores (M (cid:1) 6.08, SD (cid:1) 1.44, ACT.Theadditional43participants(34%)receivedapartialdoseof
n (cid:1) 51) than ACT (M (cid:1) 4.92, SD (cid:1) 1.91, n (cid:1) 27). Missing therapy:13participantsattendedonesession(5ACT,8CBT)and30
treatment credibility data from the first 24 ACT participants10 participants(15ineachACTandCBT)attendedtwoto11therapy
resulted in a lower sample size in this group. When the first 24 sessions.Theportionofparticipantswhodidnotcompletethefull12
CBTparticipantswereexcludedfromanalyses,groupdifferences
sessionsdidnotdifferbygroup,(cid:5)2(1)(cid:1)0.40,ns.Finally,thetotal
held:F(1,62)(cid:1)6.34,p(cid:1).01,(cid:3)2(cid:1).09,withCBTagainshowing number of treatment sessions attended by the ITT sample did not
significantly higher scores (M (cid:1)p 6.00, SD (cid:1) 1.53, n (cid:1) 37) than differbygroup:CBTM(cid:1)9.62(SD(cid:1)4.08),ACTM(cid:1)9.37(SD(cid:1)
ACT(M(cid:1)4.92,SD(cid:1)1.91,n(cid:1)27). 4.05),F(1,126)(cid:1)0.12,p(cid:1).73,(cid:3) p2(cid:1).00.
Primary Outcomes
Therapist Competence and Treatment Integrity
Table2providesthemeansandstandarddeviationsforprimary
Therapist Competence scale scores (e.g., “knowledge of treat-
outcomes at each assessment point. We conducted separate ITT
ment,”“skillindeliveringtreatment,”and“relationshipwithclient”;
1(cid:1)poor,3(cid:1)good,5(cid:1)excellent)indicated“good”therapistskills andtreatmentcompleteranalyses.Completeranalysesarereported
inCBT(M(cid:1)3.08,SD(cid:1)0.64)andACT(M(cid:1)3.25,SD(cid:1)0.77). when they differ in significance or effect size from the ITT
analyses.Effectsizesforwithin-groupandbetween-groupchange
ACT therapists and CBT therapists did not significantly differ on
competencyratings,F(1,77)(cid:1)1.17,p(cid:1).28,(cid:3)2(cid:1).02. are listed by group in Table 3. Table 4 provides the means,
Cognitivetherapyadherencescoreswerehighp erforCBT(M(cid:1) standarddeviations,effectsizes,anddiagnosticresponseratesfor
62.23,SD(cid:1)18.07)thanACT(M(cid:1)5.03,SD(cid:1)9.83),F(1,87)(cid:1) CSRoutcomesatPostforeachanxietydisorder.Individualdisor-
316.88, p (cid:2) .001, (cid:3)2 (cid:1) .76. Conversely, ACT adherence scores der outcomes were not analyzed or discussed further, however,
werehigherforACTp (M(cid:1)82.26,SD(cid:1)18.04)thanCBT(M(cid:1) because we did not design or power this study to examine group
3.94,SD(cid:1)6.40),F(1,87)(cid:1)813.58,p(cid:2).001,(cid:3)2(cid:1).90.Onthe differencesinoutcomesforindividualanxietydisorders.
p
Behavioral Adherence scale, CBT (M (cid:1) 47.41, SD (cid:1) 23.59)
scored significantly higher than ACT (M (cid:1) 25.35, SD (cid:1) 18.83), Primary Outcome Change Slopes: ITT Sample
F(1,87)(cid:1)22.77,p(cid:2).001,(cid:3)2(cid:1).21;however,thisscaleincluded
p Anxiety-specificoutcomes. Withtheintercept(0)represent-
a range of behavioral items such as therapist modeling that are
ing Pre, the HLM ITT model for CSR outcomes showed signifi-
morecommonlyusedinCBT.Weexploredgroupdifferenceson
cant effects of linear, quadratic, and cubic change over time (all
behavioralexposure-relateditemsfromtheBehavioralAdherence
ps (cid:2) .001), but no significant Group (cid:8) Time interactions. How-
scale; differences between CBT (M (cid:1) 14.25, SD (cid:1) 18.34) and
ever,aftertreatment,thegroupsshowedsignificantdifferencesin
ACT(M(cid:1)8.01,SD(cid:1)11.77)onbehavioralexposureitems(p(cid:1)
CSR linear slope (within the full model accounting for group on
.07,(cid:3)2(cid:1).04)didnotreachfullsignificance.TheGeneralTherapy
p higher order change terms and all time points with intercept
Adherence scale did not differ significantly between CBT (M (cid:1)
representingPost)suchthatACTcontinuedtoimprovefromPost
96.89,SD(cid:1)9.86)andACT(M(cid:1)99.10,SD(cid:1)4.27),F(1,87)(cid:1)
1.72,p(cid:1).19,(cid:3)2(cid:1).02.Thecombinedresultsshowthattherapists
p
exhibitedstrongadherencetotheirassignedtreatment. 10Thisoccurredduetoadministrativeerrorinwhichitwasnotunder-
Totestthepossibilitythattherapiststreatingindifferentcondi- stoodthatthetreatmentcredibilitymeasureshouldbeadministeredtoboth
tions varied in competence, we compared CBT-only, ACT-only, theCBTandACTparticipants.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
758 ARCHETAL.
Table2
Means(SDs)forPrimaryOutcomesatEachAssessmentPoint
Measureandcondition Pre-treatment Post-treatment 6-monthfollow-up 12-monthfollow-up
Anxiety-specificoutcomes
Clinicalseverityrating
ACT 5.70(0.89) 3.11(2.21) 2.77(2.39) 2.33(1.98)
CBT 5.55(0.94) 2.90(2.12) 2.67(2.24) 2.94(2.52)
AnxietySensitivityIndex
ACT 31.81(11.25) 18.65(11.89) 14.56(10.14) 17.05(12.62)
CBT 27.60(11.81) 18.68(11.16) 20.47(12.90) 15.64(8.04)
PennStateWorryQuestionnaire
ACT 46.52(11.93) 39.89(11.01) 37.79(10.87) 39.32(12.26)
CBT 45.00(12.82) 37.63(15.22) 37.72(13.04) 37.14(12.72)
FearQuestionnaire(avoidance)
ACT 5.84(2.34) 4.13(2.37) 4.00(2.66) 4.28(2.72)
CBT 5.34(2.95) 4.06(2.96) 4.22(3.12) 3.82(2.70)
Broaderoutcomes
QualityofLifeIndex
ACT 0.19(1.85) 1.42(1.88) 0.50(1.43) 1.17(1.51)
CBT 0.55(2.10) 1.78(1.35) 1.45(1.52) 1.86(1.88)
AcceptanceandActionQuestionnaire–16
ACT 59.01(12.35) 70.82(13.14) 72.14(10.86) 71.71(11.42)
CBT 58.49(11.84) 69.43(14.75) 68.38(13.76) 68.43(11.65)
Note. ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy.
to 12mFU, whereas CBT maintained but did not continue to flexibility than CBT (see Figure 2C). An HLM covariance struc-
improveasmuch,B(cid:1)0.58,SE(cid:1)0.28,t(126)(cid:1)2.03,p(cid:1).04, turebestfitthedataforthese12mFUoutcomes.
d (cid:1) 1.26 (effect size of group slope difference from Post to
12mFU;seeFigure2A).TheCSRslopesaftertreatmentwerebest
Primary Outcomes at 12mFU: Completer Sample
fitwithinaHMLMunrestrictedcovariancemodel.
The HLM ITT model for ASI, PSWQ, and FQ outcomes Anxiety-specific outcomes. At 12mFU, ACT was assigned
showed significant effects of linear, quadratic, and cubic change significantlylowerCSRratingsfortheprincipalanxietydisorderthan
over time (all ps (cid:2) .01), but no significant Group (cid:8) Time inter- CBT,B(cid:1)1.01,SE(cid:1)0.49,t(83)(cid:1)2.04,p(cid:1).04,d(cid:1)1.10.11A
actionsfrompre-topost-treatmentoraftertreatment. homogenousLevel1varianceHMLMmodelbestfittheCSRdata.At
Broaderoutcomes. TheHLMITTmodelsforAAQandQOLI this assessment point (12mFU), PD/A status was unrelated to CSR
outcomes showed significant effects of linear, quadratic, and cubic outcomes (see Results section), bolstering the significance of this
changeovertime(allps(cid:2).001),butnosignificantGroup(cid:8)Time finding.ThegroupsdidnotdiffersignificantlyontheASI,PSWQ,or
interactionsfrompre-topost-treatmentoraftertreatment. FQ.
Broader outcomes. At 12mFU, CBT showed higher QOLI
Primary Outcome Change Slopes: Completer Sample valuesthanACT,B(cid:1)0.68,SE(cid:1)0.32,t(65)(cid:1)2.12,p(cid:1).03,d(cid:1)
0.34.ACTdemonstratedhigherAAQscoresthanCBT,B(cid:1)6.76,
Anxiety-specific outcomes. Completers evidenced a similar SE(cid:1)2.65,t(66)(cid:1)2.65,p(cid:1).01,d(cid:1)0.56.
butsmallerGroup(cid:8)LinearSlopeinteractionforCSRaftertreatment,
B(cid:1)0.43,SE(cid:1)0.21,t(77)(cid:1)2.05,p(cid:1).04,d(cid:1)0.93,favoringACT.
AHMLMhomogenouscovariancestructurebestfitthedata. Secondary Outcomes
Use of additional psychotherapy and medication. There
Primary Outcomes at Post: ITT Sample
werenogroupdifferencesatPost,6mFU,or12mFUinuseofnewor
Anxiety-specificandbroaderoutcomes. AtPost,ACTand
any(e.g.,neworcontinued)psychotropicmedication(allps(cid:4).44;
CBTdidnotdiffersignificantlyonanyanxiety-specificorbroader see supplemental materials). For dropped medication, there was no
outcomemeasures.
11Due to the fact that study selection criteria required a CSR of 4 or
Primary Outcomes at 12mFU: ITT Sample
above,thepre-treatmentCSRrangewasrestricted.Thus,thepre-treatment
standarddeviation,whichservesasthedenominatorintheFeingold(2009)
Anxiety-specific outcomes. At 12mFU, ACT and CBT did
effectsizeformula,waslessthanhalfthestandarddeviationofthe12mFU
notdifferonanyanxiety-specificoutcomes.
CSRs in magnitude (whereas pre-treatment standard deviations on other
Broader outcomes. At 12mFU, CBT demonstrated higher
outcomemeasuresweregreaterthanorequaltotheirstandarddeviations
QOLI ratings than ACT, B (cid:1) 0.83, SE (cid:1) 0.41, t(113) 2.05, p (cid:1)
at 12mFU). If we use the standard deviation at 12mFU to compute the
.04, d (cid:1) 0.42 (see Figure 2B). In addition, group differences in effectsizefor12mFUgroupdifferencesonCSR,d(cid:1)0.44.Similarly,ifwe
AAQ approached significance, B (cid:1) 5.10, SE (cid:1) 2.86, t(117) (cid:1) use the post-treatment CSR standard deviation to compute the group
1.78,p(cid:1).08,d(cid:1)0.42,withACTshowinggreaterpsychological differenceinITTchangeslopesfromPost-12mFU,d(cid:1).54.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 759
Table3
EffectSizes(d)ofWithin-andBetween-SubjectEffectsforPrimaryOutcomes
Quadratic:Effectsize
Quadratic:(cid:9) (d)
Betweengroups
Outcome ACT CBT differenceind ACT CBT ACT CBT
Anxiety-specificoutcomes
CSR
LinearPre–Post (cid:6)3.74 (cid:6)3.46 0.28 0.71 0.73 0.82 0.84
LinearPost–6mFU (cid:6)1.98 (cid:6)1.78 0.20
Linear6–12mFU (cid:6)0.46 (cid:6)0.08 0.38
ASI
LinearPre–Post (cid:6)1.18 (cid:6)0.63 0.55 3.08 1.39 0.26 0.12
LinearPost–6mFU (cid:6)0.65 (cid:6)0.39 0.26
Linear6–12mFU (cid:6)0.12 (cid:6)0.15 0.03
PSWQ
LinearPre–Post (cid:6)0.74 (cid:6)0.64 0.10 2.00 1.64 0.17 0.14
LinearPost–6mFU (cid:6)0.40 (cid:6)0.36 0.04
Linear6–12mFU (cid:6)0.06 (cid:6)0.07 0.01
FQ
LinearPre–Post (cid:6)0.83 (cid:6)0.52 0.31 0.34 0.61 0.13 0.22
LinearPost–6mFU (cid:6)0.38 (cid:6)0.27 0.11
Linear6–12mFU 0.05 (cid:6)0.02 0.08
Broaderoutcomes
AAQa
LinearPre–Post 1.16 0.90 0.26 (cid:6)3.20 (cid:6)2.70 (cid:6)0.27 (cid:6)0.22
LinearPost–6mFU 0.63 0.45 0.18
Linear6–12mFU 0.10 0.00 0.10
QOLIa
LinearPre–Post 0.43 0.43 0.00 (cid:6)0.15 (cid:6)0.21 (cid:6)0.08 (cid:6)0.11
LinearPost–6mFU 0.21 0.26 0.05
Linear6–12mFU 0.00 0.12 0.12
Note. Forthesakeofclarity,effectsizesreflecthierarchicallinearmodeling(HLM)modelswithlinearandquadratictimetermsonly.Thesepartialmodel
effectsizesdifferinmagnitudefromtheeffectsizesreportedinthetextbasedonthefullcubicmodels.Quadratictermsareinvariantacrossassessment
points.ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy;CSR(cid:1)AnxietyDisordersInterviewSchedule–IV(ADIS–IV)
principaldisorderclinicalseverityratings;ASI(cid:1)AnxietySensitivityIndex;PSWQ(cid:1)PennStateWorryQuestionnaire;FQ(cid:1)MainTargetPhobiaScale
(behavioralavoidancerating)fromtheFearQuestionnaire;AAQ(cid:1)AcceptanceandActionQuestionnaire–16;QOLI(cid:1)QualityofLifeInventory;Pre(cid:1)
pre-treatment;Post(cid:1)post-treatment;FU(cid:1)follow-up;6–12mFU(cid:1)6-to12-monthfollow-up.
aHigherscoresindicateimprovement.
groupdifferenceat6mFU(p(cid:4).69),withsamplesizesat12mFUtoo psychotherapy at 6mFU was not covaried in subsequent analyses.
small to compare. At Post, however, CBT resulted in borderline Exploratory analyses showed, however, that ACT patients who re-
greaterdroppedmedicationthanACT,B(cid:1)2.13,SE(cid:1)1.10,p(cid:1).05 mainedsevere(CSR4(cid:7))followingtreatmentweresomewhatmore
(p (cid:1) .053), Exp(B) (cid:1) 8.42 (95% CI [0.97, 73.06]), with 37.04% likelytoseekadditionaltreatmentthanCBTpatientswhoremained
(10/27) of CBT versus 7.14% (1/14) of ACT participants dropping severe(p(cid:1).07;seesupplementalmaterials).
medicationfromPretoPost.Becausetherewerenogroupdifferences Generalization of treatment effects. The groups did not
in overall medication use at Post (p (cid:1) .86), however, we did not differ significantly in the number of co-occurring anxiety, mood,
furtheranalyzethisborderlinesignificantfinding. oranxietyandmooddisorderscombinedatPre(ps(cid:4).18).Nordid
Thegroupsdidnotdifferinnew,dropped,oranyoutsidepsycho- thegroupsdiffersignificantlyinratesofreductionofco-occurring
therapyuseateitherPostor12mFU(ps(cid:4).26).At6mFU,groupsdid disorders over time, with both groups showing decreases in co-
notdifferonnew(p(cid:1).13)psychotherapy;however,ACTreported occurringdisordersfollowingtreatment(seeTable5).
greateruseofanypsychotherapy(e.g.,neworcontinued)thanCBT,
B(cid:1)1.29,SE(cid:1)0.63,Wald(1)(cid:1)4.28,p(cid:1).04,Exp(B)(cid:1)3.65(95%
Treatment Response Rates
CI[1.07,12.42]):39%(11/28)ofACTparticipantsversus19%(5/27)
ofCBTparticipants.Toexploretheclinicalimpactofthisfinding,we The groups did not significantly differ in treatment response
reran the CSR analyses dropping the participants who reported any rates(seeTable6).
psychotherapyuseat6mFUandfoundthattheresultsfollowedthe
samepatternastheITTanalysisreportedabove.Further,weassessed
Discussion
whether psychotherapy use at 6mFU predicted principal diagnosis
CSRsat6mFUor12mFUandfoundthatitdidnot(ps(cid:4).4forboth Withinarandomizedclinicaltrial,weaimedtotesttheefficacy
ACT and CBT). Given these two sets of null findings, additional ofACTrelativetoagold-standardtreatmentforanxietydisorders,
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
760 ARCHETAL.
Table4
Means(SDs)forPrimaryOutcomesbyDisorder
Anxietydisorderaand Linear/quadraticdeffectsize
measure Pre Postb 6mFUb 12mFUb forPre–Postc %CSR(cid:2)3atPost
Panicdisorderwithorwithoutagoraphobia
ClinicalSeverityRating
ACT(n(cid:1)18Pre) 5.56(0.78) 2.40(2.27) 2.00(2.74) 2.00(2.08) (cid:6)4.24/0.93 60.00%(6/10)
CBT(n(cid:1)35Pre) 5.57(0.88) 2.22(2.15) 2.59(2.45) 2.58(2.84) (cid:6)4.02/1.02 69.56%(16/23)
AnxietySensitivityIndex
ACT(n(cid:1)17Pre) 37.29(6.73) 25.56(12.39) 26.67(12.42) 23.60(14.12) (cid:6)0.98/0.19
CBT(n(cid:1)33Pre) 32.03(9.57) 17.63(10.87) 18.72(8.96) 15.29(8.88) (cid:6)1.31/0.32
Socialanxietydisorder
ClinicalSeverityRating
ACT(n(cid:1)13Pre) 5.46(0.88) 4.33(1.73) 3.43(2.07) 2.60(2.07) (cid:6)0.93 44.44%(4/9)
CBT(n(cid:1)12Pre) 5.75(1.14) 3.56(1.24) 3.33(1.32) 4.00(2.00) (cid:6)0.59 66.67%(6/9)
FQ–SocialPhobiasubscale
ACT(n(cid:1)11Pre) 17.45(9.78) 16.63(7.60) 14.80(9.68) 17.20(9.52) (cid:6)0.56/0.19
CBT(n(cid:1)10Pre) 20.60(11.01) 14.67(8.26) 14.67(6.67) 17.86(6.96) (cid:6)0.54/0.16
Generalizedanxietydisorder
ClinicalSeverityRating
ACT(n(cid:1)14Pre) 6.07(0.73) 1.80(1.69) 1.75(2.19) 2.00(1.55) (cid:6)5.70/1.47 80.00%(8/10)
CBT(n(cid:1)12Pre) 5.25(0.97) 3.00(2.45) 0.00(0.00) 1.50(3.00) (cid:6)2.97/0.58 44.44%(4/9)
PennStateWorry
Questionnaire
ACT(n(cid:1)12Pre) 50.50(10.83) 35.26(8.81) 35.17(5.64) 36.09(17.64) (cid:6)0.58
CBT(n(cid:1)11Pre) 52.14(10.34) 42.43(14.65) 37.20(13.81) 40.75(12.09) (cid:6)0.25
Obsessive-compulsivedisorder
ClinicalSeverityRating
ACT(n(cid:1)9Pre) 5.67(1.23) 4.00(2.24) 4.00(2.74) 2.00(2.83) (cid:6)2.67/0.52 28.57%(2/7)
CBT(n(cid:1)8Pre) 5.88(0.84) 5.00(1.58) 4.50(2.38) 3.50(2.52) (cid:6)1.03/0.15 20.00%(1/5)
PI–WSUR
ACT(n(cid:1)7Pre) 36.69(17.61) 37.50(24.37) 28.25(18.95) 26.98(13.69) (cid:6)0.07
CBT(n(cid:1)5Pre) 40.60(23.93) 27.25(11.47) 35.00(22.63) 28.00(18.38) (cid:6)0.25
Note. ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy;Pre(cid:1)pre-treatment;Post(cid:1)post-treatment;6mFU(cid:1)6-month
follow-up;12mFU(cid:1)12-monthfollow-up;CSR(cid:1)ClinicalSeverityRating;FQ(cid:1)FearQuestionnaire;PI–WSUR(cid:1)PaduaInventory—WashingtonState
UniversityRevised. aWedidnotcomputeseparatemeansorstandarddeviationsforspecificphobiaparticipantsbecauseoftheirlownumbers(n(cid:1)6). bTheserepresentthe
meanandstandarddeviationforparticipantswithdataateachassessmentpoint. cForeaseofcomparisonwithfull-sampledatareportedinTable3,we
employedthestandarddeviationfromtheentiresampleasthedenominatorintheFeingold(2009)effectsizemagnitudeformula.Thisresultedinsomewhat
moreconservative(lower)effectsizesforsomemeasures.Further,slopesarebasedonchangeovertimewithallassessmentpointsinthemodel(Pre
through12mFU).Therefore,effectsizesfromPretoPostreflecttheslopeofchangeacrossallassessmentpointswhichcandifferfromtheslopeofPre
toPostchangealone.
CBT. Because ACT represents a transdiagnostic treatment ap- Primary Outcomes
proach (Hayes et al., 1999), we focused on a mixed anxiety
disordersample.Weexploredthedegreetowhicheachtreatment On all primary outcomes, ACT and CBT showed substantial
reduced anxiety symptoms and tested the hypothesis that ACT improvement from pre- to post-treatment. On anxiety-specific
would improve on measures of quality of life and psychological outcomes,within-grouplineareffectsizesinACTandCBTfrom
flexibilitytoagreaterextentthanCBT. pre-topost-treatmentrangedfromverylargeforprincipaldisorder
Overall, the findings demonstrated that ACT and CBT did not severity (CSR) to moderate or large for other anxiety outcomes.
differ significantly at post-treatment on either anxiety-specific or Thus, both treatments were highly efficacious. Anxiety-related
broaderoutcomes.Groupdifferencesemergedduringthefollow-up outcomes continued to improve through the 6-month follow-up
interval,however,withACTshowingsuperiorityoverCBTonprin- assessment within both ACT and CBT. From 6 to 12 months,
cipaldisorderseverityandpsychologicalflexibilityoutcomes.How- improvement slowed but treatment gains endured. On broader
ever,groupdifferencesarecomplicatedbythefactthatsignificantly outcomes,bothgroupsshowedlargelinearimprovementsinpsy-
more ACT participants utilized outside psychotherapy during the chological flexibility and more moderate linear improvements in
initialfollow-upintervalthanCBTparticipants.Ourhypothesisthat quality of life from pre- to post-treatment. Broader outcomes
ACTwouldimprovemorethanCBTonbroaderoutcomesmetwith continue to improve or endure through follow-up. In summary,
limited support; on one broad outcome, ACT improved more than ACT and CBT resulted in significant improvements from pre- to
CBTbutontheother,CBTimprovedmorethanACT. post-treatment that were maintained or improved upon during
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 761
A. Principal disorder severity (CSR) principal anxiety disorder severity than CBT among those who
completed treatment. This finding is consistent with a previous
6
study (Lappalainen et al., 2007) that found that ACT resulted in
5 more symptom improvement that CBT, albeit in a much smaller
4 sample (n (cid:1) 28) of unselected outpatients. However, since more
ACT than CBT patients in the current study utilized outside
3 ACT
therapy during the initial follow-up interval, we cannot fully de-
2 CBT termine whether ACT’s superiority resulted from the ACT treat-
1 ment alone or ACT plus additional psychotherapy. Excluding
patients using non-study therapy from the principal disorder se-
0
verity analyses, however, did not change the pattern of results,
pre post 6m 12m
suggesting that use of non-study therapy did not influence the
principaldisorderseverityfindings.
B. Quality of Life Index (QOLI) For broader outcomes, one unexpected finding was that CBT
2 participantsreportedsignificantlyhigherqualityoflifethanACT
at12-monthfollow-up,adifferenceofmoderateeffectsize.Ithad
beenhypothesizedthattheexplicitfocusonvaluedlivinginACT
1.5
would lead to greater improvements in quality of life. Conceiv-
ably, our measure of quality of life was too general to capture
1 ACT
values-specific improvements. Consistent with hypotheses, how-
CBT
ever, ACT participants reported higher levels of psychological
0.5
flexibility than CBT at 12-month follow-up on a measure specif-
icallydesignedtocaptureACT-relatedimprovement(Hayesetal.,
0 2004). Please refer to the supplemental materials for further dis-
pre post 6m 12m
cussionofprimaryoutcomes.
Finally,ACTandCBTproducedsimilarratesofreliablechange,
C. Acceptance and Action Questionnaire-16 (AAQ) diagnosticimprovement,andhighend-statefunctioning,comparable
toourrecentreviewshowingthatonaveragethemeanresponserate
75
forCBTacrossanxietydisorderstudiesfrom2000–2011was51.36%
70 atpost-treatment(180studies)and54.80%atfollow-up(71studies;
Loerinc, Meuret, Twohig, Rosenfield, & Craske, 2012). Very few
65
studies(ofthe180)usedreliablechangeindexmethodstocompute
60 ACT treatmentresponserates,butthefewthatdid(e.g.,Addisetal.,2004;
Carter, Sbrocco, Gore, Marin, & Lewis, 2003) evidenced response
CBT 55 ratescomparabletothoseinthepresentstudy.
50
Secondary Outcomes
45
pre post 6m 12m
Asnotedabove,moreACTthanCBTpatientsreportednon-study
psychotherapy (new or continued psychotherapy) at the 6-month
Figure2. A–C:Primaryoutcomesintheintent-to-treat(ITT)samplewith follow-upassessment,althoughtherewerenogroupdifferencesinthe
acceptance and commitment therapy (ACT) versus cognitive behavioral
initiationofnewpsychotherapyduringthisperiodnorinmedication
therapy(CBT)differences.CSR(cid:1)ClinicalSeverityRating;m(cid:1)month.
use,noranygroupdifferencesonthesevariablesat12-monthfollow-
up. Reasons for this group difference, nonetheless, were explored.
ThedatashowedsomesupportforthenotionthatACTpatientswho
follow-up,onbothanxiety-specificandbroaderoutcomes.Further,
remained distressed following treatment were more likely to seek
improvements were evident across two different dimensions of
treatment response, namely, more objective, clinician-rated CSR additionalpsychotherapythanCBTpatientswhoremaineddistressed.
outcomesaswellassubjective,patient-ratedself-reportoutcomes. Another possibility is that the broader focus on exploring personal
From the end of treatment through the 12-month follow-up, values, pursuing meaningful life behaviors, and contacting the full
several noteworthy group differences emerged. On anxiety- rangeofemotionsinACTinspiredpatientstocontinueengagingin
specific outcomes, ACT demonstrated a steeper linear improve- psychotherapy.
ment rate than CBT in the principal disorder severity rating, a BothACTandCBTresultedinrobustreductionsinco-occurring
difference of large effect size. ACT’s steeper improvement rates moodandanxietydisorders.Thisfindingdemonstratesthattreatment
resulted in lower principal disorder severity ratings than CBT at effectsgeneralizedinbothgroups,replicatingandextendingprevious
the 12-month follow-up, again of large effect size, although sta- workonthebroadereffectsofCBTforpanicdisorderandgeneralized
tisticallysignificanteffectswerelimitedtothecompletersample. anxiety disorder (e.g., Borkovec, Abel, & Newman, 1995; Tsao,
Over the long term, therefore, ACT more effectively reduced Mystkowski,Zucker,&Craske,2005).
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si elcitra
sihT
762 ARCHETAL.
Table5
Co-OccurringDisorders:RatesandImprovementAmongParticipantsWithDataatEachTimePoint
ACT:(cid:10)slopeover CBT:(cid:10)slope
%ofparticipantswithco-occurring time,oddsratio overtime,odds
disorders ACT CBT Between-group(cid:5)2 [CI]a‘ ratio[CI]
Pre-treatment
Anxietydisorders 39.3%(22/56) 28.2%(20/71) p(cid:1).19
Mooddisorders 23.2%(13/56) 23.9%(17/71) p(cid:1).92
Moodoranxiety 52.8%(29/56) 41.2%(28/68) p(cid:1).24
Post-treatment
Anxietydisorders 10.8%(4/37) 8.7%(4/46) p(cid:1).75 0.38(cid:1)(cid:1)(cid:1)[0.24,0.59] 0.47(cid:1)(cid:1)[0.29,0.78]
Mooddisorders 8.1%(3/37) 2.2%(1/46) p(cid:1).21 0.43(cid:1)(cid:1)[0.23,0.83] 0.36(cid:1)(cid:1)[0.17,0.76]
Moodoranxiety 18.9%(7/37) 8.7%(4/46) p(cid:1).17 0.41(cid:1)(cid:1)(cid:1)[0.26,0.63] 0.44(cid:1)(cid:1)[0.26,0.75]
6mFU
Anxietydisorders 7.7%(2/26) 5.6%(2/36) p(cid:1).85
Mooddisorders 3.8%(1/26) 2.8%(1/36) p(cid:1).85
Moodoranxiety 11.5%(3/26) 5.6%(2/36) p(cid:1).77
12mFU
Anxietydisorders 5.9%(1/17) 7.4%(2/27) p(cid:1).85
Mooddisorders 5.9%(1/17) 7.4%(2/27) p(cid:1).85
Moodoranxiety 11.8%(2/17) 14.8%(4/27) p(cid:1).77
Note. ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy;6mFU(cid:1)6-monthfollow-up;12mFU(cid:1)12-monthfollow-up.
aTheoddsratiosarebasedonfixedgeneralizedhierarchicallinearmodeling(GHLM)lineartimeslopesforwithin-groupchangeovertimefordichotomous
outcomes, covarying pre-treatment Clinical Severity Rating (CSR) for the principal diagnosis at the model’s intercept. They are reported here at
post-treatmentbutcharacterizethelinearchangerateoverthepre-treatmentto12mFUperiod.
(cid:1)(cid:1)p(cid:2).01. (cid:1)(cid:1)(cid:1)p(cid:2).001.
Treatment and Therapist Variables transportationoptions,andtraveltimestoandfromtreatmentoften
exceeded45mineachway.Second,ourassessmentsincludeda2-
AttritionrateswererelativelyhighacrossbothACTandCBT;
to3-hrphysiologicallaboratorysessionthatwasstronglyanxiety
however,nogroupdifferencesemerged.Attritionwascomparable
provokingformanypatients(e.g.,involvinghyperventilation,neg-
tosomelargetrialsofCBTforanxietydisorders(e.g.,Barlowet
ativepictureslideviewing),whichmayhavediscouragedpatients
al.,2000)butwashigherthanthemeanattrition(23%)reportedin
ameta-analysisofCBTstudiesforanxietydisorders(Hofmann& from study completion. Third, unlike many studies where treat-
Smits,2008).Althoughattritionreasonsformanypatientsremain mentisfreeorlowcostforall,mostpatientspaidfortreatmentand
unknown, we suspect that four features of our study may have incurred significant parking costs. Fourth, we offered few incen-
contributedtoattrition.First,thestudytookplaceinadifficultto tivesfortreatmentcompletionandfailedtosufficientlyincentivize
locate, high-traffic, parking-challenged clinic with limited public post-treatment and follow-up assessment completion. Higher in-
Table6
ResponseRatesonTreatmentResponseIndices
Assessment CBT ACT (cid:5)2 p Cramer’sv
Showsreliablechangeaonatleasttwooffouranxiety-specificoutcomes
Post-treatment 44.4%(16/36) 56.7%(17/30) 0.98 .32 .12
6-monthFU 53.6%(15/28) 47.1%(8/17) 0.09 .76 .05
12-monthFU 52.2%(12/23) 52.6%(10/19) 0.00 .98 .01
Showsreliablechangeaandhighend-statefunctioningbasedontwooffouranxiety-specificoutcomes
Post-treatment 47.2%(17/36) 50.0%(15/30) 0.05 .82 .03
6-monthFU 53.6%(15/28) 47.1%(8/17) 0.18 .67 .06
12-monthFU 39.1%(9/23) 47.4%(9/19) 0.29 .59 .08
ShowsreliableCSRchangeaanddoesnotmeetclinicaldiagnosticcriteria(CSR(cid:2)3)
Post-treatment 51.0%(25/49) 44.7%(17/38) 0.34 .56 .06
6-monthFU 59.5%(22/37) 44.4%(12/27) 1.41 .24 .15
12-monthFU 50.0%(16/32) 54.5%(12/22) 0.11 .74 .05
Note. ACT(cid:1)acceptanceandcommitmenttherapy;CBT(cid:1)cognitivebehavioraltherapy;CSR(cid:1)ClinicalSeverityRating;FU(cid:1)follow-up.
aReliablechangerequiredthefollowingminimumimprovementvaluesfrompre-treatment(seesupplementalmaterialsforcomputationaldetails):principal
disorderCSR(cid:1)2.75,PennStateWorryQuestionnaire(cid:1)10.03,AnxietySensitivityIndex(cid:1)10.48,FearQuestionnaireMainTargetPhobiaAvoidance
rating(cid:1)1.97.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 763
centives may have been particularly needed in a study with such treatment. Future ACT/CBT studies should assess group differ-
significanttreatmentbarriers(e.g.,longtraveltimes,parkingfees encesinstatedreasonsforattrition.Sixth,weutilizedasingle-item
anddifficulties,treatmentfees). ratingfromtheFearQuestionnaireforbehavioralavoidancedueto
An important finding to emerge from blind treatment integrity the lack of avoidance measures relevant to all anxiety disorders.
ratings was that ACT and CBT were clearly distinguished from Seventh, we used a website to generate the randomization se-
oneanotherandthattherapistsstronglyadheredtotheirdesignated quence, whereas use of an external agency would have been
treatment. Despite the use of novice student therapists, therapists preferable.Eighth,wedidnotincludeano-treatmentortreatment-
averaged “good” overall skills across both treatments with no as-usualcontrolgroup,whichmayhaveobscuredourcapacityto
differencesbetweentreatmentgroups.Therapiststreatingpatients assessimprovementduetotreatmentversusthepassageoftime.It
inbothCBTandACTnonethelessevidencedsignificantlyhigher has been argued, however, that comparing a newer to a well-
competence than therapists treating in CBT only. Principal diag- established treatment does not require a no-treatment or waitlist
nostic severity analyses of patients treated only by “both-type” control group and is more ethical without one (Kazdin, 2002).
therapists showed the same pattern of outcomes, however, sug- Also, the roughly equal number of treatment sessions devoted to
gestingthatthesedifferencesdidnotimpactoverallstudyfindings. behavioral exposure in ACT and CBT may have obscured treat-
Earlyintreatment,CBTwasratedasamorecredibletreatment mentdifferences.Thetwotreatmentconditionswerematchedon
thanACTbyamediumeffectsize.Thus,ACTtherapistswerenot exposure,albeitframedwithdifferentintents,giventhepotencyof
assuccessfulasCBTtherapistsinconvincingpatientsearlyonthat exposureasachangeagent.Thisfeaturemayhavealteredtheway
theyofferedacredibletreatment.Thisdifferencedidnotappearto that ACT is typically done. In addition, the Penn State Worry
influence attrition rates, which did not differ by group. Conceiv- Questionnairescoresatpre-treatmentintheGADsubsamplewere
ably, abstract ideas of acceptance and creative hopelessness in considerably lower than those in recently published randomized
initialACTsessions(ratherthanconcreteskillsinCBT)contrib- trialsforGAD(Newmanetal.,2011;Roemeretal.,2008),which
utedtoadiminishedsenseoftreatmentcredibility.Futurestudies may hold implications for the interpretation of findings in this
should assess treatment credibility regularly throughout ACT to subgroup. Finally, regarding the generalizability of our findings,
determinewhetherACTfollowsadelayedtrajectoryinconvincing oursamplelargelyreflectedtheracial,ethnic,andsexdistribution
patientsthatitofferssomethingcredible,orwhetherACTpatients of U.S. residents at the time of data collection (U.S. Census
remain skeptical throughout treatment but improve anyway. The Bureau, 2012), supporting the broad generalizability of our find-
latter would suggest that treatment credibility is relatively unim- ings. On the other hand, our sample was relatively educated (the
portanttothesuccessofACT.Certainly,inthecurrentstudy,the averageparticipanthadcompleted3.5yearsofcollege),andthus,
lowered credibility ratings relative to CBT did not appear to ourfindingsmaynotgeneralizetolesseducatedsamples.Further,
disadvantageACToutcomesrelativetoCBToutcomes. we cannot assume that treatment was equally efficacious across
racialsubgroupsbecausewelackedthestatisticalpowertoexam-
inewhetheroutcomesdifferedbyrace.Thisremainsanimportant
Study Limitations
questionforfutureresearch.
Several study limitations should be noted. First, our mixed
anxietydisordersamplelimitstheconclusionsthatmaybedrawn
Summary and Conclusion
about any single anxiety disorder. Anxiety disorders typically
co-occurathighrateswithotheranxietydisordersandsharemany Toourknowledge,thisstudyrepresentsthefirstrandomizedclin-
common features (see Barlow, 2002; Craske et al., 2009), how- ical trial comparing ACT and CBT for anxiety disorders. Despite
ever, strengthening the ecological validity of this approach. Sec- differences in underlying treatment models, the overall findings are
ond,relativelyhighattritionratesmayhaveresultedinunderesti- characterizedbysimilaritiesintheimmediateandlong-termimpactof
mated treatment effects or compromised ability to accurately bothtreatments.Wehavearguedelsewhere(Arch&Craske,2008)
assesstreatment-relatedimprovementsintheITTsample.Onthe that ACT and CBT for anxiety disorders may represent different
otherhand,weutilizedasophisticatedstatisticalapproach(HLM, approaches to affecting common therapeutic changes. This study
HMLM)thatutilizedpatientswithincompletedataanddrewupon largelysupportsthishypothesis.Ontheotherhand,somedifferences
allavailabledataintheITTanalyses;wealsoconductedseparate did emerge, in that CBT resulted in higher quality of life, whereas
completersanalyses.Third,wedidnotassesstherapistallegiance, ACTresultedingreaterpsychologicalflexibility,and,amongthose
which may have impacted treatment results given that the study whocompletedtreatment,lowerprincipalanxietydisorderseverity,
wasconductedwithinaCBT-renownedresearchclinic.Basedon overthefollow-up.Overall,ourfindingssuggestthatACTisahighly
the relatively inexperienced and junior nature of the therapists, viable treatment alternative to CBT, the current gold-standard psy-
however,allegianceisunlikelytobeasignificantfactor.Therapist chosocialtreatmentforanxietydisorders.Further,theypavetheway
experienceraisesanotherlimitation,whichisthattheresultsmay forfutureinvestigationsofforwhomeachtreatmentapproachismost
differ in the hands of more experienced therapists. Fourth, CBT effective and the shared versus unique mechanisms of therapeutic
supervision was conducted onsite in a face-to-face manner, change.
whereasmostACTsupervisionwasconductedviaphoneorSkype
withoffsitesupervisors.Wedidnotassesssupervisionqualityand
References
thus could not investigate the impact of this group difference.
Fifth, we did not systematically assess reasons for attrition and, Addis, M. E., Hatgis, C., Bourne, L., Krasnow, A. D., Jacob, K., &
thus,couldnotassesswhetherACTandCBTdifferedintheextent Mansfield,A.(2004).Effectivenessofcognitive–behavioraltreatment
towhichpatientsdroppedoutbecausetheywereunsatisfiedwith forpanicdisorderversustreatmentasusualinamanagedcaresetting.
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
764 ARCHETAL.
Journal of Consulting and Clinical Psychology, 72, 625–635. doi: Craske,M.G.(2003).Originsofphobiasandanxietydisorders:Whymore
10.1037/0022-006X.72.4.625 womenthanmen?Oxford,England:Elsevier.
AmericanPsychiatricAssociation.(1994).Diagnosticandstatisticalman- Craske,M.G.(2005).Cognitive-behavioraltreatmentofanxietydisorders.
ualofmentaldisorders(4thed.).Washington,DC:Author. Unpublishedmanuscript.
Arch,J.J.,&Craske,M.G.(2008).Acceptanceandcommitmenttherapy Craske,M.G.,Farchione,T.J.,Allen,L.B.,Barrios,V.,Stoyanova,M.,
andcognitivebehavioraltherapyforanxietydisorders:Differenttreat- &Rose,R.(2007).Cognitivebehavioraltherapyforpanicdisorderand
ments,similarmechanisms?ClinicalPsychology:ScienceandPractice, comorbidity:Moreofthesameorlessofmore?BehaviourResearchand
15,263–279.doi:10.1111/j.1468-2850.2008.00137.x Therapy,45,1095–1109.doi:10.1016/j.brat.2006.09.006
Barlow,D.H.(2002).Anxietyanditsdisorders:Thenatureandtreatment Craske, M. G., Rauch, S. L., Ursano, R., Prenoveau, J., Pine, D. S., &
ofanxietyandpanic(2nded.).NewYork,NY:GuilfordPress. Zinbarg, R. E. (2009). What is an anxiety disorder? Depression and
Barlow,D.H.,&Cerny,J.A.(1988).Psychologicaltreatmentofpanic. Anxiety,26,1066–1085.doi:10.1002/da.20633
NewYork,NY:GuilfordPress. Craske,M.G.,Roy-Byrne,P.,Stein,M.B.,Sullivan,G.,Hazlett-Stevens,
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000). H.,Bystritsky,A.,&Sherbourne,C.(2006).CBTintensityandoutcome
Cognitive-behavioral therapy, imipramine, or their combination for for panic disorder in a primary care setting. Behavior Therapy, 37,
panicdisorder:Arandomizedcontrolledtrial.JournaloftheAmerican 112–119.doi:10.1016/j.beth.2005.05.003
MedicalAssociation,283,2529–2536.doi:10.1001/jama.283.19.2529 Craske,M.G.,Stein,M.B.,Sullivan,G.,Sherbourne,C.,Bystritsky,A.,
Beck,A.T.,Emery,G.,&Greenberg,R.L.(1985).Anxietydisordersand Rose, R. D., ... Roy-Byrne, P. (2011). Disorder-specific impact of
phobias:Acognitiveperspective.NewYork,NY:BasicBooks. coordinated anxiety learning and management treatment for anxiety
Bond,F.W.,&Bunce,D.(2000).Mediatorsofchangeinemotion-focusedand disordersinprimarycare.ArchivesofGeneralPsychiatry,68,378–388.
problem-focusedworksitestressmanagementinterventions.JournalofOccu- doi:10.1001/archgenpsychiatry.2011.25
pationalHealthPsychology,5,156–163.doi:10.1037/1076-8998.5.1.156 Dalrymple,K.L.,&Herbert,J.D.(2007).Acceptanceandcommitment
Bond,F.W.,&Bunce,D.(2003).Theroleofacceptanceandjobcontrol therapyforgeneralizedsocialanxietydisorder:Apilotstudy.Behavior
in mental health, job satisfaction, and work performance. Journal of Modification,31,543–568.doi:10.1177/0145445507302037
AppliedPsychology,88,1057–1067.doi:10.1037/0021-9010.88.6.1057 Eifert,G.H.,&Forsyth,J.P.(2005).Acceptanceandcommitmenttherapy
Bond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. C., Guenole, N., for anxiety disorders: A practitioner’s treatment guide to using mind-
Orcutt,H.K.,...Zettle,R.D.(2011).Preliminarypsychometricprop- fulness,acceptance,andvalues-basedbehaviorchangestrategies.New
ertiesoftheAcceptanceandActionQuestionnaire—II:Arevisedmea- York,NY:GuilfordPress.
sure of psychological flexibility and experiential avoidance. Behavior Eifert,G.H.,Forsyth,J.P.,Arch,J.J.,Keller,M.,Langer,D.,&Espejo,
Therapy,42,676–688. N.(2009).Acceptanceandcommitmenttherapyforanxietydisorders:
Borkovec,T.D.,Abel,J.L.,&Newman,H.(1995).Effectsofpsycho- Casestudiesusingaunifiedtreatmentprotocol.CognitiveandBehav-
therapyoncomorbidconditionsingeneralizedanxietydisorder.Journal ioralPractice,16,368–385.doi:10.1016/j.cbpra.2009.06.001
ofConsultingandClinicalPsychology,63,479–483.doi:10.1037/0022- Feingold, A. (2009). Effect sizes for growth-modeling analysis for con-
006X.63.3.479 trolled clinical trials in the same metric as for classical analysis. Psy-
Borkovec, T. D., & Nau, S. D. (1972). Credibility of analogue therapy chologicalMethods,14,43–53.doi:10.1037/a0014699
rationales.JournalofBehaviorTherapyandExperimentalPsychiatry,3, Forman,E.M.,Herbert,J.D.,Moitra,E.,Yeomans,P.D.,&Geller,P.A.
257–260.doi:10.1016/0005-7916(72)90045-6 (2007). A randomized controlled effectiveness trial of acceptance and
Brewin, C. R. (1996). Theoretical foundations of cognitive-behavioral commitmenttherapyandcognitivetherapyforanxietyanddepression.
therapyforanxietyanddepression.AnnualReviewofPsychology,47, BehaviorModification,31,772–799.doi:10.1177/0145445507302202
33–57.doi:10.1146/annurev.psych.47.1.33 Frisch,M.B.(1994a).ManualandtreatmentguidefortheQualityofLife
Brown, T. A., Antony, M. M., & Barlow, D. H. (1992). Psychometric Inventory.Minneapolis,MN:PearsonAssessments.
propertiesofthePennStateWorryQuestionnaireinaclinicalanxiety Frisch,M.B.(1994b).QualityofLifeInventory(QOLI).Minneapolis,MN:
disorders sample. Behaviour Research and Therapy, 30, 33–37. doi: NationalComputerSystems.
10.1016/0005-7967(92)90093-V Frisch,M.B.,Clark,M.P.,Rouse,S.V.,Rudd,M.D.,Paweleck,J.,&
Brown,T.A.,&Barlow,D.H.(1995).Long-termoutcomeincognitive- Greenstone,A.(2005).Predictiveandtreatmentvalidityoflifesatisfac-
behavioraltreatmentofpanicdisorder:Clinicalpredictorsandalterna- tion and the Quality of Life Inventory. Assessment, 12, 66–78. doi:
tivestrategiesforassessment.JournalofConsultingandClinicalPsy- 10.1177/1073191104268006
chology,63,754–765.doi:10.1037/0022-006X.63.5.754 Guttman, I. (1973). Premium and protection of several procedures for
Brown,T.A.,DiNardo,P.A.,&Barlow,D.H.(1994).AnxietyDisorders dealingwithoutlierswhensamplesizesaremoderateandlarge.Tech-
Interview Schedule for DSM–IV. Albany, NY: Center for Stress and nometrics,15,385–404.
AnxietyDisorders. Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and
Butler,A.C.,Chapman,J.E.,Forman,E.M.,&Beck,A.T.(2006).The commitment therapy: An experiential approach to behavior change.
empirical status of cognitive-behavioral therapy: A review of meta- NewYork,NY:GuilfordPress.
analyses. Clinical Psychology Review, 26, 17–31. doi:10.1016/ Hayes,S.C.,Strosahl,K.,Wilson,K.G.,Bissett,R.T.,Pistorello,J.,Toarmino,D.,
j.cpr.2005.07.003 ...McCurry,S.M.(2004).Measuringexperientialavoidance:Apreliminary
Carter, M. M., Sbrocco, T., Gore, K. L., Marin, N. W., & Lewis, E. L. testofaworkingmodel.PsychologicalRecord,54,553–578.
(2003).Cognitive–behavioralgrouptherapyversusawait-listcontrolin Hedeker,D.,&Gibbons,R.D.(2006).Longitudinaldataanalysis.Hobo-
thetreatmentofAfricanAmericanwomenwithpanicdisorder.Cogni- ken,NJ:Wiley-Interscience.
tive Therapy and Research, 27, 505–518. doi:10.1023/A: Hofmann,S.G.,&Smits,J.A.J.(2008).Cognitive-behavioraltherapyfor
1026350903639 adult anxiety disorders: A meta-analysis of randomized placebo-
Chambless,D.L.,&Hollon,S.D.(1998).Definingempiricallysupported controlledtrials.JournalofClinicalPsychiatry,69,621–632.
therapies. Journal of Consulting and Clinical Psychology, 66, 7–18. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical
doi:10.1037/0022-006X.66.1.7 approach to defining meaningful change in psychotherapy research.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences JournalofConsultingandClinicalPsychology,59,12–19.doi:10.1037/
(2nded.).Hillsdale,NJ:Erlbaum. 0022-006X.59.1.12
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot
ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT
CBTVERSUSACTFORANXIETYDISORDERS 765
Kazdin A. E. (2002). Research design in clinical psychology (4th ed.). HLM6:Hierarchicallinearandnonlinearmodeling.Lincolnwood,IL:
NeedhamHeights,MA:Allyn&Bacon. ScientificSoftwareInternational.
Lappalainen, R., Lehtonen, T., Skarp, E., Taubert, E., Ojanen, M., & Raudenbush, S. W., Bryk, A. S., & Congdon, R. (2004). HLM 6 for
Hayes, S. C. (2007). The impact of CBT and ACT models using Windows [Computer software]. Lincolnwood, IL: Scientific Software
psychology trainee therapists: A preliminary controlled effectiveness International.
trial. Behavior Modification, 31, 488–511. doi:10.1177/ Raudenbush, S. W., & Liu, X.-F. (2000). Statistical power and optimal
0145445506298436 designformultisiterandomizedtrials.PsychologicalMethods,5,199–
Loerinc,A.G.,Meuret,A.E.,Twohig,M.P.,Rosenfield,D.,&Craske, 213.doi:10.1037/1082-989X.5.2.199
M.G.(2012).CBTforanxietydisorders:Treatmentrespondercriteria Reiss, S., Peterson, R., Gursky, D., & McNally, R. (1986). Anxiety
andresponserates.Manuscriptsubmittedforpublication. sensitivity,anxietyfrequency,andthepredictionoffearfulness.Behav-
Longmore,R.J.,&Worrell,M.(2007).Doweneedtochallengethoughts iour Research and Therapy, 24, 1–8. doi:10.1016/0005-
incognitivebehavioraltherapy?ClinicalPsychologyReview,27,173– 7967(86)90143-9
187.doi:10.1016/j.cpr.2006.08.001 Roemer,L.,&Orsillo,S.M.(2007).Anopentrialofanacceptance-based
Maassen, G. H. (2004). The standard error in the Jacobson and Truax behaviortherapyforgeneralizedanxietydisorder.BehaviorTherapy,38,
Reliable Change Index: The classical approach to the assessment of 72–85.doi:10.1016/j.beth.2006.04.004
reliablechange.JournaloftheInternationalNeuropsychologicalSoci- Roemer,L.,Orsillo,S.M.,&Salters-Pedneault,K.(2008).Efficacyofan
ety,10,888–893.doi:10.1017/S1355617704106097 acceptance-based behavior therapy for generalized anxiety disorder:
Marks, I. M., & Mathews, A. M. (1979). Brief standard self-rating for Evaluationinarandomizedcontrolledtrial.JournalofConsultingand
phobic patients. Behaviour Research and Therapy, 17, 263–267. doi: ClinicalPsychology,76,1083–1089.doi:10.1037/a0012720
10.1016/0005-7967(79)90041-X Taylor,S.,Koch,W.J.,&McNally,R.(1992).Howdoesanxietysensi-
McGrath,K.B.,Forman,E.M.,&Herbert,J.D.(2012).Developmentand tivityvaryacrosstheanxietydisorders?JournalofAnxietyDisorders,6,
validation of the ACT/CT Adherence and Competence Rating Scale. 249–259.doi:10.1016/0887-6185(92)90037-8
Manuscriptinpreparation. Taylor, S., Zvolensky, M. J., Cox, B. J., Deacon, B., Heimberg, R. G.,
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990). Ledley,D.R.,...Cardenas,S.J.(2007).Robustdimensionsofanxiety
Development and validation of the Penn State Worry Questionnaire. sensitivity:DevelopmentandinitialvalidationoftheAnxietySensitivity
Behaviour Research and Therapy, 28, 487–495. doi:10.1016/0005- Index—3. Psychological Assessment, 19, 176–188. doi:10.1037/1040-
7967(90)90135-6 3590.19.2.176
Newman,M.G.,Castonguay,L.,Borkovec,T.D.,Fisher,A.J.,Boswell, Tolin, D. F. (2010). Is cognitive behavioral therapy more effective than
J.F.,Szkodny,L.E.,&Nordberg,S.S.(2011).Arandomizedcontrolled other therapies? A meta-analytic review. Clinical Psychology Review,
trial of cognitive-behavioral therapy for generalized anxiety disorder 30,710–720.doi:10.1016/j.cpr.2010.05.003
withintegratedtechniquesfromemotion-focusedandinterpersonalther- Tsao, J. C., Mystkowski, J. L., Zucker, B. G., & Craske, M. G. (2005).
apies. Journal of Consulting and Clinical Psychology, 79, 171–181. Impactofcognitive-behavioraltherapyforpanicdisorderoncomorbid-
doi:10.1037/a0022489 ity: A controlled investigation. Behaviour Research and Therapy, 43,
Norton, P. J., & Price, E. C. (2007). A meta-analytic review of adult 959–970.doi:10.1016/j.brat.2004.11.013
cognitive-behavioral treatment outcome across the anxiety disorders. Twohig,M.P.,Hayes,S.C.,Plumb,J.C.,Pruitt,L.D.,Collins,A.B.,
Journal of Nervous and Mental Disease, 195, 521–531. doi:10.1097/ Hazlett-Stevens,H.,&Woidneck,M.R.(2010).Arandomizedclinical
01.nmd.0000253843.70149.9a trialofacceptanceandcommitmenttherapyvs.progressiverelaxation
Odgaard, E. C., & Fowler, R. L. (2010). Confidence intervals for effect trainingforobsessivecompulsivedisorder.JournalofConsultingand
sizes:ComplianceandclinicalsignificanceintheJournalofConsulting ClinicalPsychology,78,705–716.doi:10.1037/a0020508
andClinicalPsychology.JournalofConsultingandClinicalPsychol- U.S.CensusBureau.(2012).StatisticalabstractoftheUnitedStates:2012.
ogy,78,287–297.doi:10.1037/a0019294 Table10.Residentpopulationbyrace,Hispanicorigin,andage:2000–
Orsillo, S. M., & Batten, S. V. (2005). Acceptance and commitment 2009. Retrieved from http://www.census.gov/compendia/statab/2012/
therapyinthetreatmentofposttraumaticstressdisorder.BehaviorMod- tables/12s0010.pdf
ification,29,95–129.doi:10.1177/0145445504270876 Wetherell,J.L.,Afari,N.,Ayers,C.R.,Stoddard,J.A.,Ruberg,J.,Sorrell,
Peterson,R.A.,&Reiss,S.(1993).AnxietySensitivityIndexRevisedtest J.T.,...Patterson,T.L.(2011).Acceptanceandcommitmenttherapy
manual.Worthington,OH:InternationalDiagnosticSystems. for generalized anxiety disorder in older adults: A preliminary report.
Rapee, R. M., Brown, T. A., Antony, M. M., & Barlow, D. H. (1992). BehaviorTherapy,42,127–134.doi:10.1016/j.beth.2010.07.002
Response to hyperventilation and inhalation of 5.5% carbon dioxide-
enrichedairacrosstheDSM–III–Ranxietydisorders.JournalofAbnor- ReceivedAugust12,2011
malPsychology,101,538–552.doi:10.1037/0021-843X.101.3.538 RevisionreceivedMarch12,2012
Raudenbush,S.W.,Bryk,A.S.,Cheong,Y.F.,&Congdon,R.(2004). AcceptedMarch13,2012 (cid:1)
.srehsilbup
deilla
sti
fo
eno
ro
noitaicossA
lacigolohcysP
naciremA
eht
yb
dethgirypoc
si
tnemucod
sihT
.yldaorb
detanimessid
eb
ot ton
si
dna
resu
laudividni
eht
fo
esu
lanosrep
eht
rof
ylelos
dednetni
si
elcitra
sihT